Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Navigation/Suche

• Forscher*innen.
  • Curriculum.
  • Publikationen.
  • Projekte.
  • Präsentationen.
  • Betreute Dipl u. Diss.
• Institutionen.
• Projekte.
• Publikationen.
• Partner.
• Geldgeber.
• Ausstattung.
• Knowhow.
• Forschungsfelder.

Linkesch Werner |

** = Publikationen gelistet in SCI/SSCI/Pubmed

2021

Originalarbeit (Zeitschrift)

** Hatzl, S; Posch, F; Rezai, A; Gornicec, M; Beham-Schmid, C; Magnes, T; Wangner, S; Deutsch, A; Greinix, H; Uhl, B; Prochazka, KT; Egle, A; Greil, R; Melchardt, T; Linkesch, W; Schulz, E; Neumeister, P Vinorelbine as substitute for vincristine in patients with diffuse large B cell lymphoma and vincristine-induced neuropathy.
Support Care Cancer. 2021; 29(9):5197-5207 Doi: 10.1007/s00520-021-06059-2 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2017

Originalarbeit (Zeitschrift)

** Sezer, O; Beksac, M; Hajek, R; Sucak, G; Cagirgan, S; Linkesch, W; Meltem Akay, O; Gülbas, Z; Nahi, H; Plesner, T; Snowden, JA; Timurağaoğlu, A; Dechow, T; Lang, A; Tuğlular, T; Drach, J; Armbrecht, G; Potamianou, A; Couturier, C; Olie, RA; Feys, C; Allietta, N; Terpos, E Effects of single-agent bortezomib as post-transplant consolidation therapy on multiple myeloma-related bone disease: a randomized phase II study.
Br J Haematol. 2017; 178(1):61-71 Doi: 10.1111/bjh.14637 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2015

Originalarbeit (Zeitschrift)

** Cerny-Reiterer, S; Rabenhorst, A; Stefanzl, G; Herndlhofer, S; Hoermann, G; Müllauer, L; Baumgartner, S; Beham-Schmid, C; Sperr, WR; Mannhalter, C; Sill, H; Linkesch, W; Arock, M; Hartmann, K; Valent, P Long-term treatment with imatinib results in profound mast cell deficiency in Ph+ chronic myeloid leukemia.
Oncotarget. 2015; 6(5):3071-3084 Doi: 10.18632/oncotarget.3074 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Pascal, L; Tucunduva, L; Ruggeri, A; Blaise, D; Ceballos, P; Chevallier, P; Cornelissen, J; Maillard, N; Tabrizi, R; Petersen, E; Linkesch, W; Sengeloev, H; Kenzey, C; Pagliuca, A; Holler, E; Einsele, H; Gluckman, E; Rocha, V; Yakoub-Agha, I; Eurocord and the European Society for Blood and Marrow Transplantation Impact of ATG-containing reduced-intensity conditioning after single- or double-unit allogeneic cord blood transplantation.
Blood. 2015; 126(8):1027-1032 Doi: 10.1182/blood-2014-09-599241 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Wasle, I; Gamerith, G; Kocher, F; Mondello, P; Jaeger, T; Walder, A; Auberger, J; Melchardt, T; Linkesch, W; Fiegl, M; Mian, M Non-pegylated liposomal doxorubicin in lymphoma: patterns of toxicity and outcome in a large observational trial.
Ann Hematol. 2015; 94(4):593-601 Doi: 10.1007/s00277-014-2250-6
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Bohm, A; Rabitsch, W; Greinix, HT; Kalhs, P; Mitterbauer, M; Schulenburg, A; Wohrer, S; Worel, N; Strunk, D; Linkesch, W; Urban, C; Schwinger, W; Peters, C; Gastl, G; Nachbaur, D; Kircher, B; Clausen, J; Auberger, J; Krieger, O; Kasparu, H; Hauser, H; Machherndl-Spandl, S; Weltermann, A; Lindner, B Allogeneic Stem Cell Transplantation In Patients With Acute Myeloid Leukemia: a report from the Austrian Stem Cell Transplantation Registry (ASCTR)
CL LYMPH MYELOM LEUK. 2015; 15: S183-S183. [Oral Communication]
Web of Science

 

** Guilaksen, SE; Skavland, J; Warzocha, K; Gavasso, S; Tosevski, V; Thielen, N; Voglova, J; Ferrant, A; Linkesch, W; Thaler, J; Lang, A; Stentoft, J; Cedde-Dahl, T; Hjorth-Hansen, H; Majeed, W; Verhoef, G; Hellmann, A; Mihaylov, GG; Dumrese, C; Giles, F; Hochhaus, A; Sopper, S; Stenke, L; Labar, B; Janssen, J; Porkka, K; Ossenkoppele, GJ; Mustjoki, S; Wolf, D; Gjertsen, BT Single-Cell Immune Signatures in Patients with Chronic Phase Chronic Myeloid Leukemia (CML) Treated with Nilotinib: An ENEST1st Sub Study
BLOOD. 2015; 126(23):
Web of Science

 

2014

Originalarbeit (Zeitschrift)

** Hopfinger, G; Nösslinger, T; Lang, A; Linkesch, W; Melchardt, T; Weiss, L; Egle, A; Greil, R Lenalidomide in combination with vorinostat and dexamethasone for the treatment of relapsed/refractory peripheral T cell lymphoma (PTCL): report of a phase I/II trial.
Ann Hematol. 2014; 93(3):459-462 Doi: 10.1007/s00277-014-2009-0
Web of Science PubMed FullText FullText_MUG

 

** Ludwig, H; Kasparu, H; Leitgeb, C; Rauch, E; Linkesch, W; Zojer, N; Greil, R; Seebacher, A; Pour, L; Weißmann, A; Adam, Z Bendamustine-bortezomib-dexamethasone is an active and well-tolerated regimen in patients with relapsed or refractory multiple myeloma.
Blood. 2014; 123(7):985-991 Doi: 10.1182/blood-2013-08-521468 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Mian, M; Wasle, I; Gamerith, G; Mondello, P; Melchardt, T; Jäger, T; Linkesch, W; Fiegl, M R-CHOP versus R-COMP: are they really equally effective?
Clin Oncol (R Coll Radiol). 2014; 26(10):648-652 Doi: 10.1016/j.clon.2014.05.012
Web of Science PubMed FullText FullText_MUG

 

** Pleyer, L; Burgstaller, S; Girschikofsky, M; Linkesch, W; Stauder, R; Pfeilstocker, M; Schreder, M; Tinchon, C; Sliwa, T; Lang, A; Sperr, WR; Krippl, P; Geissler, D; Voskova, D; Schlick, K; Thaler, J; Machherndl-Spandl, S; Theiler, G; Eckmüllner, O; Greil, R Azacitidine in 302 patients with WHO-defined acute myeloid leukemia: results from the Austrian Azacitidine Registry of the AGMT-Study Group.
Ann Hematol. 2014; 93(11):1825-1838 Doi: 10.1007/s00277-014-2126-9 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Pleyer, L; Germing, U; Sperr, WR; Linkesch, W; Burgstaller, S; Stauder, R; Girschikofsky, M; Schreder, M; Pfeilstocker, M; Lang, A; Sliwa, T; Geissler, D; Schlick, K; Placher-Sorko, G; Theiler, G; Thaler, J; Mitrovic, M; Neureiter, D; Valent, P; Greil, R Azacitidine in CMML: matched-pair analyses of daily-life patients reveal modest effects on clinical course and survival.
Leuk Res. 2014; 38(4):475-483 Doi: 10.1016/j.leukres.2014.01.006 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Robin, M; Giannotti, F; Deconinck, E; Mohty, M; Michallet, M; Sanz, G; Chevallier, P; Cahn, JY; Legrand, F; Rovira, M; Passweg, J; Sierra, J; Nguyen, S; Maillard, N; Yakoub-Agha, I; Linkesch, W; Cannell, P; Marcatti, M; Bay, JO; Chalandon, Y; Kröger, N; Gluckman, E; Rocha, V; Olavarria, E; Ruggeri, A; Eurocord and Chronic Malignancies Working Party-European Group for Blood and Marrow Transplantation (CMWP-EBMT) Unrelated cord blood transplantation for patients with primary or secondary myelofibrosis.
Biol Blood Marrow Transplant. 2014; 20(11):1841-1846 Doi: 10.1016/j.bbmt.2014.06.011 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Tucunduva, L; Ruggeri, A; Sanz, G; Furst, S; Cornelissen, J; Linkesch, W; Mannone, L; Ribera, JM; Veelken, H; Yakoub-Agha, I; González Valentín, ME; Schots, R; Arcese, W; Montesinos, P; Labopin, M; Gluckman, E; Mohty, M; Rocha, V Impact of minimal residual disease on outcomes after umbilical cord blood transplantation for adults with Philadelphia-positive acute lymphoblastic leukaemia: an analysis on behalf of Eurocord, Cord Blood Committee and the Acute Leukaemia working party of the European group for Blood and Marrow Transplantation.
Br J Haematol. 2014; 166(5):749-757 Doi: 10.1111/bjh.12970 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Tucunduva, L; Ruggeri, A; Sanz, G; Furst, S; Socié, G; Michallet, M; Arcese, W; Milpied, N; Yakoub-Agha, I; Linkesch, W; Cornelissen, J; Mannone, L; Iori, AP; Ribera, JM; Sanz, J; Montesinos, P; Purtill, D; Labopin, M; Gluckman, E; Mohty, M; Rocha, V Risk factors for outcomes after unrelated cord blood transplantation for adults with acute lymphoblastic leukemia: a report on behalf of Eurocord and the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Bone Marrow Transplant. 2014; 49(7):887-894 Doi: 10.1038/bmt.2014.72 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Valentin, A; Troppan, K; Pfeilstöcker, M; Nösslinger, T; Linkesch, W; Neumeister, P Safety and tolerability of intrathecal liposomal cytarabine as central nervous system prophylaxis in patients with acute lymphoblastic leukemia.
Leuk Lymphoma. 2014; 55(8):1739-1742 Doi: 10.3109/10428194.2013.853765
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Bohm, A; Rabitsch, W; Greinix, HT; Kalhs, P; Mitterbauer, M; Schulenburg, A; Wohrer, S; Worel, N; Strunk, D; Linkesch, W; Urban, C; Schwinger, W; Peters, C; Gastl, G; Nachbaur, D; Kircher, B; Clausen, J; Auberger, J; Krieger, O; Kasparu, H; Machherndl-Spandl, S; Weltermann, A; Lindner, B Allogeneic Stem Cell Transplantation in patients with acute myeloid leukemia: a report from the Austrian Stem Cell Transplantation Registry (ASCTR)
ONCOL RES TREAT. 2014; 37: 134-134. [Poster]
Web of Science

 

** Noesslinger, T; Moestl, M; Tinchon, C; Koller, E; Linkesch, W; Keil, F Autologous Stem Cell Transplantation with Benda-BEAM (Bendamustine, Etoposide, Cytarabine, Melphalan) in Aggressive Non Hodgkin and Hodgkin's Lymphoma
BLOOD. 2014; 124(21): Doi: 10.1182/blood.V124.21.3982.3982
Web of Science FullText FullText_MUG

 

** Pleyer, L; Burgstaller, S; Stauder, R; Girschikofsky, M; Linkesch, W; Pfeilstocker, M; Autzinger, EM; Tinchon, C; Sliwa, T; Lang, A; Sperr, WR; Geissler, D; Krippl, P; Voskova, D; Rossmann, DH; Schlick, K; Thaler, J; Halter, B; Machherndl-Spandl, S; Theiler, G; Valent, P; Eckmullner, O; Greil, R Azacitidine in Patients with Acute Myeloid Leukemia: Assessing the Potential Negative Impact of Elevated Baseline White Blood Cell Count on Outcome
BLOOD. 2014; 124(21): Doi: 10.1182/blood.V124.21.2284.2284
Web of Science FullText FullText_MUG

 

** Pleyer, L; Burgstaller, S; Stauder, R; Girschikofsky, M; Linkesch, W; Pfeilstocker, M; Autzinger, EM; Tinchon, C; Sliwa, T; Lang, A; Sperr, WR; Geissler, D; Krippl, P; Voskova, D; Rossmann, DH; Schlick, K; Thaler, J; Halter, B; Machherndl-Spandl, S; Theiler, G; Valent, P; Eckmullner, O; Greil, R Azacitidine in Acute Myeloid Leukemia: Comparison of Patients with AML-MRF Vs AML-NOS Enrolled in the Austrian Azacitidine Registry
BLOOD. 2014; 124(21):
Web of Science

 

** Pleyer, L; Burgstaller, S; Stauder, R; Girschikofsky, M; Linkesch, W; Pfeilstocker, M; Autzinger, EM; Tinchon, C; Sliwa, T; Lang, A; Sperr, WR; Geissler, D; Krippl, P; Voskova, D; Rossmann, DH; Schlick, K; Thaler, J; Halter, B; Machherndl-Spandl, S; Theiler, G; Valent, P; Eckmullner, O; Greil, R Azacitidine in Patients with Relapsed/Refractory Acute Myeloid Leukemia : Retrospective Analysis of the Austrian Azacitidine Registry
BLOOD. 2014; 124(21):
Web of Science

 

** Pleyer, L; Burgstaller, S; Stauder, R; Girschikofsky, M; Linkesch, W; Pfeilstocker, M; Autzinger, EM; Tinchon, C; Sliwa, T; Lang, A; Sperr, WR; Geissler, D; Krippl, P; Voskova, D; Rossmann, DH; Schlick, K; Thaler, J; Halter, B; Machherndl-Spandl, S; Theiler, G; Valent, P; Eckmullner, O; Greil, R Azacitidine in Patients with Acute Myeloid Leukemia: Impact of Intermediate-Risk Vs High-Risk Cytogenetics on Patient Outcomes
BLOOD. 2014; 124(21):
Web of Science

 

** Pleyer, L; Burgstaller, S; Stauder, R; Girschikofsky, M; Linkesch, W; Pfeilstoker, M; Autzinger, EM; Tinchon, C; Sliwa, T; Lang, A; Sperr, WR; Geissler, D; Krippl, P; Voskova, D; Rossmann, DH; Schlick, K; Thaler, J; Halter, B; Machherndl-Spandl, S; Theiler, G; Valent, P; Eckmullner, O; Greil, R Azacitidine in Patients with Treatment-Related Acute Myeloid Leukemia: Retrospective Analysis of the Austrian Azacitidine Registry
BLOOD. 2014; 124(21): Doi: 10.1182/blood.V124.21.3681.3681
Web of Science FullText FullText_MUG

 

** Sezer,O; Beksac,M; Hajek,R; Sucak,G; Cacirgan,S; Linkesch,W; Akay, OM; Armbrecht,G; Plesner,T; Snowden,JA; Nahi,H; Gulbas,Z; Potamianou,A; Couturier,C; Olie,R; Feys,C; Allietta,N; Terpos,E Effects of single-Agent Bortezomib as posttransplant Consolidation on Multiple Myeloma-related Bone Didease; First Results from a Multicenter,randomized Phase 2 Study
Haematologica. 2014; 99(S1):362-362.-19th Congress of the European Hematology Association; June 12-15, 2014; Milan, ITALY. [Poster]
Web of Science

 

2013

Originalarbeit (Zeitschrift)

** Pleyer, L; Stauder, R; Burgstaller, S; Schreder, M; Tinchon, C; Pfeilstocker, M; Steinkirchner, S; Melchardt, T; Mitrovic, M; Girschikofsky, M; Lang, A; Krippl, P; Sliwa, T; Egle, A; Linkesch, W; Voskova, D; Angermann, H; Greil, R Azacitidine in patients with WHO-defined AML - results of 155 patients from the Austrian Azacitidine Registry of the AGMT-Study Group.
J Hematol Oncol. 2013; 6(4):32-32 Doi: 10.1186/1756-8722-6-32 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Scholz, CW; Pinto, A; Linkesch, W; Lindén, O; Viardot, A; Keller, U; Hess, G; Lastoria, S; Lerch, K; Frigeri, F; Arcamone, M; Stroux, A; Frericks, B; Pott, C; Pezzutto, A 90Yttrium-Ibritumomab-Tiuxetan as First-Line Treatment for Follicular Lymphoma: 30 Months of Follow-Up Data From an International Multicenter Phase II Clinical Trial.
J Clin Oncol. 2013; 31(3):308-313 Doi: 10.1200/JCO.2011.41.1553 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Troch, M; Kiesewetter, B; Willenbacher, W; Willenbacher, E; Zebisch, A; Linkesch, W; Fridrik, M; Müllauer, L; Greil, R; Raderer, M Rituximab plus subcutaneous cladribine in patients with extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue: a phase II study by the Arbeitsgemeinschaft Medikamentose Tumortherapie.
Haematologica. 2013; 98(2):264-268 Doi: 10.3324/haematol.2012.072587 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Unteregger, M; Valentin, A; Zinke-Cerwenka, W; Troppan, K; Deutsch, A; Cerroni, L; Linkesch, W; Neumeister, P Unrelated SCT induces long-term remission in patients with blastic plasmacytoid dendritic cell neoplasm.
Bone Marrow Transplant. 2013; 48(6):799-802 Doi: 10.1038/bmt.2012.242 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Boehm, A; Rabitsch, W; Greinix, HT; Kalhs, P; Mitterbauer, M; Schulenburg, A; Woehrer, S; Worel, N; Strunk, D; Linkesch, W; Urban, C; Schwinger, W; Peters, C; Gastl, G; Nachbaur, D; Kircher, B; Clausen, J; Auberger, J; Krieger, O; Kasparu, H; Hauser, H; Machherndl-Spandl, S; Weltermann, A; Lindner, B; Allogeneic stem cell transplantation in patients with acute myeloid leukaemia: a report from the Austrian Stem Cell Transplantation Registry (ASCTR).
BONE MARROW TRANSPLANT. BONE MARROW TRANSPLANTATION48: S393-S393. LONDON: NATURE PUBLISHING GROUP; ( Presented at: 39th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation (EBMT), London, ENGLAND, APR 07-10, 2013) [Poster]
Web of Science

 

** Cerny-Reiterer, S; Herndlhofer, S; Stefanzl, G; Blatt, K; Hormann, G; Mullauer, L; Beham-Schmid, C; Baumgartner, S; Sperr, WSR; Mannhalter, C; Linkesch, W; Valent, P The tyrosine kinase inhibitor (TKI) imatinib produces mast cell deficiency in Ph plus chronic myeloid leukemia
ONKOLOGIE. 2013; 36: 63-63. [Oral Communication]
Web of Science

 

** Kqiku, X; Kovacs, G; Abdyli, L; Reitter, S; Linkesch, W; Olschewski, H Screening for early pulmonary vascular changes in patients with chronic myeloproliferative disorders
ONKOLOGIE. 2013; 36: 64-64. [Poster]
Web of Science

 

** Linkesch, W Graft versus Host Disease
ONKOLOGIE. 2013; 36: 24-24. [Keynote lecture]
Web of Science

 

** Linkesch, W; Zinke-Cerwenka, W; Wolfler, A; Still, H; Neumeister, P UCBT with low-dose ATG in adult patients
ONKOLOGIE. 2013; 36: 127-128. [Poster]
Web of Science

 

** Noesslinger, T; Keil, F; Mostl, M; Tinchon, C; Koller, E; Mulabecirovic, A; Unteregger, MJ; Hundsamer, A; Sallaberger, E; Linkesch, W Autologous stem cell transplantation with BeEAM (bendamustine, etoposide, cytarabine, melphalan) in aggressive NHL and Hodgkin Lymphoma
ONKOLOGIE. 2013; 36: 7-7.-Jahrestagung der Österr. ,Deutschen und Schweizer Gesellschaften für Hämatologie und OnkologieOKT; OKT 15-16, 2013; Wien, Austria. [Poster]
Web of Science

 

** Schmidt, S; Burgstaller, S; Linkesch, W; Greil, R; Schlogl, E; Fridrik, M; Krieger, O; Petzer, A; Lang, A; Mitterer, M; Valent, P; Walder, A; Sliwa, T; Keil, F; Korger, M; Hausler, C; Woll, E; Oexle, H; Schnallinger, M; Pober, M; Rochau, U; Siebert, U; Thaler, J; Gastl, G Updated report of the Austrian CML registry
ONKOLOGIE. 2013; 36: 63-63.-Jahrestagung der Österr., Deutschen und Schweizer Gesellschaften für Hämatologie und Onkolofie; OKT 15-16, 2013; Wien, Austria. [Poster]
Web of Science

 

** Tucunduva, L; Ruggeri, A; Sanz, G; Furst, S; Cornelissen, J; Linkesch, W; Mannone, L; Ribera, JM; Montesinos, P; Gluckman, E; Mohty, M; Rocha, V; Risk factors and outcomes after umbilical cord blood transplant for adults with Philadelphia positive acute lymphoblastic leukaemia and impact of minimal residual disease before transplant.
BONE MARROW TRANSPLANT. BONE MARROW TRANSPLANTATION48: S42-S42. LONDON: NATURE PUBLISHING GROUP; ( Presented at: 39th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation (EBMT), London, ENGLAND, APR 07-10, 2013) [Oral Communication]
Web of Science

 

** Wenzl, K; Troppan, K; Deutsch, AJA; Linkesch, W; Neumeister, P; Beham-Schmid, C; Distinct Chemokine Receptor Profile In Chronic Lymphocytic Leukaemia and Richter Transformed Diffuse Large B Cell Lymphomas Compared To Germinal Center B Cells and De Novo Diffuse Large B Cell Lymphomas.
BLOOD. BLOOD122: WASHINGTON: AMER SOC HEMATOLOGY; ( Presented at: 55th Annual Meeting of the American-Society-of-Hematology, New Orleans, LA, DEC 07-10, 2013) Doi: 10.1182/blood.V122.21.4852.4852
Web of Science FullText FullText_MUG

 

2012

Originalarbeit (Zeitschrift)

** Finke, J; Schmoor, C; Bethge, WA; Ottinger, HD; Stelljes, M; Zander, AR; Volin, L; Heim, DA; Schwerdtfeger, R; Kolbe, K; Mayer, J; Maertens, JA; Linkesch, W; Holler, E; Koza, V; Bornhäuser, M; Einsele, H; Bertz, H; Grishina, O; Socié, G; ATG-Fresenius Trial Group Prognostic factors affecting outcome after allogeneic transplantation for hematological malignancies from unrelated donors: results from a randomized trial.
Biol Blood Marrow Transplant. 2012; 18(11):1716-1726 Doi: 10.1016/j.bbmt.2012.06.001 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Fried, I; Bodner, C; Pichler, MM; Lind, K; Beham-Schmid, C; Quehenberger, F; Sperr, WR; Linkesch, W; Sill, H; Wölfler, A Frequency, onset and clinical impact of somatic DNMT3A mutations in therapy-related and secondary acute myeloid leukemia.
Haematologica. 2012; 97(2):246-250 Doi: 10.3324/haematol.2011.051581 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Hoenigl, M; Salzer, HJ; Raggam, RB; Valentin, T; Rohn, A; Woelfler, A; Seeber, K; Linkesch, W; Krause, R Impact of galactomannan testing on the prevalence of invasive aspergillosis in patients with hematological malignancies.
Med Mycol. 2012; 50(3):266-269 Doi: 10.3109/13693786.2011.603102 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Hoenigl, M; Strenger, V; Buzina, W; Valentin, T; Koidl, C; Wölfler, A; Seeber, K; Valentin, A; Strohmeier, AT; Zollner-Schwetz, I; Raggam, RB; Urban, C; Lass-Flörl, C; Linkesch, W; Krause, R European Organization for the Research and Treatment of Cancer/Mycoses Study Group (EORTC/MSG) host factors and invasive fungal infections in patients with haematological malignancies.
J Antimicrob Chemother. 2012; 67(8):2029-2033 Doi: 10.1093/jac/dks155 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Pabinger, I; Gastl, G; Steurer, M; Sormann, S; Fillitz, M; Friedl, J; Geissler, D; Geissler, K; Greil, R; Knöbl, P; Kozek-Langenecker, S; Krippl, P; Kyrle, P; Lang, A; Linkesch, W; Ludwig, H; Müller, M; Panzer, S; Pittermann, E; Thaler, J; Weltermann, A Primary immune thrombocytopenia in adults: diagnostics and treatment consensus statement of the Austrian Society of Hematology and Oncology (GHO)
Wien Klin Wochenschr. 2012; 124(3-4):111-123 Doi: 10.1007/s00508-012-0123-3
Web of Science PubMed FullText FullText_MUG

 

** Rosenmayr, A; Pointner-Prager, M; Mitterschiffthaler, A; Bozic, L; Pelzmann, B; Tüchler, H; Fae, I; Fischer, GF; Greinix, HT; Peters, Ch; Kalhs, P; Krieger, O; Linkesch, W; Nachbaur, D; Urban, Ch; Posch, U; Lanzer, G; Gabriel, Ch; Schennach, H; Mayr, WR What are a patient's current chances of finding a matched unrelated donor? Twenty years' central search experience in a small country.
Bone Marrow Transplant. 2012; 47(2):172-180 Doi: 10.1038/bmt.2011.67 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Schlick, K; Aigelsreiter, A; Pichler, M; Reitter, S; Neumeister, P; Hoefler, G; Beham-Schmid, C; Linkesch, W Histiocytic sarcoma - targeted therapy: novel therapeutic options? A series of 4 cases.
Onkologie. 2012; 35(7-8):447-450 Doi: 10.1159/000340066 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

** Valent, P; Gastl, G; Geissler, K; Greil, R; Hantschel, O; Lang, A; Linkesch, W; Lion, T; Petzer, AL; Pittermann, E; Pleyer, L; Thaler, J; Wolf, D Nilotinib as frontline and second-line therapy in chronic myeloid leukemia: Open questions.
Crit Rev Oncol Hematol. 2012; 82(3):370-377 Doi: 10.1016/j.critrevonc.2011.08.002
Web of Science PubMed FullText FullText_MUG

 

Kurzbericht/Letter

** Reitter, S; Rohn, A; Schmidt, HH; Linkesch, W Upfront radioimmunotherapy represents an effective and safe therapeutic option in cutaneous B-cell non-Hodgkin lymphoma.
Ann Hematol. 2012; 91(1): 129-130. Doi: 10.1007/s00277-011-1216-1 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Keil, F; Nosslinger, T; Unteregger, MJ; Mostl, M; Tinchon, C; Koller, E; Mulabecirovic, A; Hundsamer, A; Linkesch, W; Autologous stem cell transplantation with BeEAM (bendamustine, etoposide, cytarabine, melphalan) in aggressive NHL and Hodgkin Lymphoma.
ONKOLOGIE. 2012; 35: 42-42.-Gemeinsame Jahrestagung der Deutschen, Österr. Und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OKT 19.23 ,2012; Stuttgart. [Poster]
Web of Science

 

** Ludwig, H; Kasparu, H; Greil, R; Leitgeb, C; Muldur, E; Rauch, E; Zojer, N; Autzinger, EM; Linkesch, W; Kuhr, T; Pour, L; Adam, Z; Treatment with Bendamustine-Bortezomib-Dexamethasone (BBD) in Relapsed/Refractory Multiple Myeloma Shows Significant Activity and Is Well Tolerated.
BLOOD. BLOOD120: WASHINGTON: AMER SOC HEMATOLOGY; ( Presented at: 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Atlanta, GA, DEC 08-11, 2012) Doi: 10.1182/blood.V120.21.943.943 [Keynote lecture]
Web of Science FullText FullText_MUG

 

** Ludwig, H; Kasparu, H; Greil, R; Leitgeb, C; Muldur, E; Rauch, E; Zojer, N; Autzinger, EM; Linkesch, W; Kuhr, T; Pour, L; Adam, Z; Treatment with Bendamustine-Bortezomib-Dexamethasone (BBD) in Relapsed/Refractory Multiple Myeloma Shows Significant Activity and Is Well Tolerated.
BLOOD. . 2012; 120(21):-54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH); DEC 08-11, 2012; Atlanta, GA. [Poster]
Web of Science

 

** Ludwig, H; Kasparu, H; Leitgeb, C; Greil, R; Rauch, E; Linkesch, W; Zojer, N; Pour, L; Fillitz, M; Adam, Z Impact of number of previous treatment lines and pre-treatment with Bortezomib or Lenalidomid on efficacy of Bortezomib-Bendamustin-Dexamethasone (BBD) in patients with relapsed/refractory Multiple Myeloma (MM).
Annals of Oncology. 2012; 23(9):348-349.-37th ESMO Congress; SEP 28-OCT 2, 2012; VIENNA, AUSTRIA. (ISBN: 1569-8041 ) [Oral Communication]
Web of Science

 

** Schmidt, S; Burgstaller, S; Linkesch, W; Greil, R; Schlogl, E; Fridrik, M; Krieger, O; Petzer, A; Lang, A; Mitterer, M; Valent, P; Walder, A; Sliwa, T; Keil, F; Korger, M; Hausler, C; Woll, E; Oexle, H; Schnallinger, M; Andel, J; Geissler, D; Pober, M; Eisterer, W; Thaler, J; Gastl, G; Updated report of the Austrian CML registry.
ONKOLOGIE. 2012; 35: 50-50.-Jahrestagung de DÖGHO; OKT 19-23, 2012; Stuttgart. [Poster]
Web of Science

 

** Sormann, S; Bauer, F; Linkesch, W; Update from the myeloma registry of the University Hospital Graz - impact of new drugs on disease management in the transplant setting.
ONKOLOGIE. 2012; 35: 146-146.-Jahrestagung der DÖGHO; OKT 19-23. 2012; Stuttgart. [Poster]
Web of Science

 

** Stojakovic, T; Zinke-Cerwenka, W; Unteregger, M; Truschnig-Wilders, M; Linkesch, W Vergleich zweier Methoden zur Bestimmung der freien Leichtketten Kappa und Lambda im Serum mit polyklonalen und monoklonalen Antikörpern.
Onkologie. 2012; 35(S6):142-142.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OCT 19-23, 2012; Stuttgart, GERMANY. [Poster]
Web of Science

 

** Troch, M; Kiesewetter, B; Willenbacher, W; Willenbacher, E; Zebisch, A; Linkesch, W; Fridrik, MA; Müllauer, L; Greil, R; Raderer, M Rituximab plus subcutaneous Cladribine in patients with extranodal marginal zone B-cell Lymphoma of the Mucosa associated tissue (MALT-Lymphoma): A Phase II study by the AGMT
Annals of Oncology. 2012; 23(9):352-352.-37th ESMO Congress; SEP 28-OCT 2, 2012; VIENNA, AUSTRIA. (ISBN: 1569-8041 ) [Poster]
Web of Science

 

** Valentin, A; Unteregger, M; Troppan, K; Zinke-Cerwenka, W; Cerroni, L; Linkesch, W; Neumeister, P; Unrelated stem cell transplantation induces long term disease control in patients with blastic plasmocytoid dendritic cell neoplasm.
ONKOLOGIE. 2012; 35: 212-213.-Jahrestagung der DÖGHO; OKT 19-23. 2012; Stuttgart. [Poster]
Web of Science

 

2011

Originalarbeit (Zeitschrift)

** Hoenigl, M; Zollner-Schwetz, I; Sill, H; Linkesch, W; Lass-Flörl, C; Schnedl, WJ; Krause, R Epidemiology of invasive fungal infections and rationale for antifungal therapy in patients with haematological malignancies.
Mycoses. 2011; 54(5):454-459 Doi: 10.1111/j.1439-0507.2010.01881.x
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Hohloch, K; Delaloye, AB; Windemuth-Kieselbach, C; Gómez-Codina, J; Linkesch, W; Jurczak, W; Cacchione, R; Suh, C; Zinzani, PL; Trümper, L Radioimmunotherapy confers long-term survival to lymphoma patients with acceptable toxicity: registry analysis by the international radioimmunotherapy network.
J Nucl Med. 2011; 52(9):1354-1360 Doi: 10.2967/jnumed.111.089920 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Hohloch, K; Zinzani, PL; Linkesch, W; Jurczak, W; Deptala, A; Lorsbach, M; Windemuth-Kiesselbach, C; Wulf, GG; Truemper, LH Radioimmunotherapy with (90)Y-ibritumomab tiuxetan is a safe and efficient treatment for patients with B-cell lymphoma relapsed after auto-SCT: an analysis of the international RIT-Network.
Bone Marrow Transplant. 2011; 46(6): 901-903. Doi: 10.1038/bmt.2010.202 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Rohn, A; Kessler, HH; Valentin, T; Linkesch, W; Neumeister, P Prophylactic oseltamivir treatment for prevention of donor-recipient influenza A H1N1 virus transmission does not compromise stem cell mobilization or engraftment.
Bone Marrow Transplant. 2011; 46(2): 312-313. Doi: 10.1038/bmt.2010.97 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Schlick, K; Regauer, S; Beham-Schmid, C; Cerroni, L; Rohn, A; Deutsch, AJ; Linkesch, W; Neumeister, P; Aigelsreiter, A Pyoderma gangrenosum heralding acute leukemia for months: diagnostic hint written on the skin.
J Clin Oncol. 2011; 29(17): e506-e508. Doi: 10.1200/JCO.2010.34.3855 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Socié, G; Schmoor, C; Bethge, WA; Ottinger, HD; Stelljes, M; Zander, AR; Volin, L; Ruutu, T; Heim, DA; Schwerdtfeger, R; Kolbe, K; Mayer, J; Maertens, JA; Linkesch, W; Holler, E; Koza, V; Bornhäuser, M; Einsele, H; Kolb, HJ; Bertz, H; Egger, M; Grishina, O; Finke, J Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius.
Blood. 2011; 117(23): 6375-6382. Doi: 10.1182/blood-2011-01-329821 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Worel, N; Rosskopf, K; Neumeister, P; Kasparu, H; Nachbaur, D; Russ, G; Namberger, K; Witt, V; Schloegl, E; Zojer, N; Linkesch, W; Kalhs, P; Greinix, HT Plerixafor and granulocyte-colony-stimulating factor (G-CSF) in patients with lymphoma and multiple myeloma previously failing mobilization with G-CSF with or without chemotherapy for autologous hematopoietic stem cell mobilization: the Austrian experience on a named patient program.
Transfusion. 2011; 51(5):968-975 Doi: 10.1111/j.1537-2995.2010.02896.x
Web of Science PubMed FullText FullText_MUG

 

** Zinke-Cerwenka, W; Valentin, A; Posch, U; Beham-Schmid, C; Groselj-Strele, A; Linkesch, W; Wölfler, A; Sill, H Reduced-intensity allografting in patients with therapy-related myeloid neoplasms and active primary malignancies.
Bone Marrow Transplant. 2011; 46(12):1540-1544 Doi: 10.1038/bmt.2011.165 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Kurzbericht/Letter

** Pichler, MM; Bodner, C; Fischer, C; Deutsch, AJ; Hiden, K; Beham-Schmid, C; Linkesch, W; Guelly, C; Sill, H; Wölfler, A Evaluation of mutations in the isocitrate dehydrogenase genes in therapy-related and secondary acute myeloid leukaemia identifies a patient with clonal evolution to IDH2 R172K homozygosity due to uniparental disomy.
Br J Haematol. 2011; 152(5): 669-672. Doi: 10.1111/j.1365-2141.2010.08404.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Editorial

** Schlick, K; Schilcher, G; Krisper, P; Neumeister, P; Linkesch, W; Beham-Schmid, C; Aigelsreiter, A Spontaneous Tumor Lysis Syndrome Presenting As Acute Renal Failure in an Adult With De Novo Aleukemic T-ALL: Value of Renal Biopsy?
J CLIN ONCOL. 2011; 29(17): E494-E496. Doi: 10.1200/JCO.2010.33.1504 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Al-Ali, HK; le Coutre, P; Duyster, J; Linkesch, W; Wolf, D; Schanz, U; Baerlocher, GM; Wackwitz, B; Heim, D ENACT (Expanding Nilotinib Access in Clinical Trials) study in adult patients (pts) with Imatinib-resistant or -intolerant Chronic Myeloid Leukemia (CML): Subgroup analysis of Pts from Germany, Austria and Switzerland (DACH)
Onkologie. 2011; 34(6):267-267.-Jahrestagung der DÖuSGHO; SEP 30-OCT 04, 2011; Basel. [Poster]
Web of Science

 

** Deutsch, AJA; Rinner, B; Stradner, MH; Angerer, H; Linkesch, W; Beham-Schmid, C; Neumeister, P Cytosporone B induces NR4A1 meditated apoptosis in aggressive lymphoma cells
ONKOLOGIE. 2011; 34: 72-72. [Poster]
Web of Science

 

** Hoenigl, M; Salzer, HJ; Raggam, RB; Valentin, T; Rohn, A; Seeber, K; Strohmaier, A; Woelfler, A; Zollner-Schwetz, I; Linkesch, W; Krause, R. Posaconazole Serum Levels And Invasive Fungal Infections In Patients With Hematologic Malignancies
Mycoses. 2011; 54(sup2):180-180.-5th Trends in Medical Mycology ; OCT 2-5, 2011; Valencia, SPAIN. (ISBN: 1439-0507 ) [Poster]
Web of Science

 

** Hoenigl, M; Salzer, HJ; Strohmaier, A; Valentin, T; Zollner-Schwetz, I; Rohn, A; Seeber, K; Grisold, AJ; Linkesch, W; Krause, R Risk Factors For Invasive Fungal Infection Among Patients With Hematologic Malignancies.
Mycoses. 2011; 54(sup2):51-51.-5th Trends in Medical Mycology ; OCT 2-5, 2011; Valencia, SPAIN. (ISBN: 1439-0507 ) [Oral Communication]
Web of Science

 

** Linkesch, W; Neumeister, P; Zinke-Cerwenka, W; Strunk, D; Sill, H UCBT with low-dose ATG in adults
BONE MARROW TRANSPLANT. 2011; 46: S128-S129. [Poster]
Web of Science

 

** Linkesch, W; Sill, H; Zinke-Cerwenka, W; Neumeister, P; Strunk, D Results of UCBT with ATG in adults.
Onkologie. 2011; 34(6):271-271.-Jahrestagung der DÖuSGHO; SEP 30-OCT 04, 2011; Basel. [Poster]
Web of Science

 

** Ludwig, H; Kasparu, H; Linkesch, W; Thaler, J; Greil, R; Leitgeb, C; Heintel, D; Rauch, E; Zojer, N; Pour, L; Seebacher, A; Adam, Z Bortezomib-Bendamustine-Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma (MM) Shows Marked Efficacy and Is Well Tolerated, but Assessment of PNP Symptoms Shows Significant Discrepancies Between Patients and Physicians
BLOOD. 2011; 118(21): 1262-1263. [Poster]
Web of Science

 

** Pleyer, L; Stauder, R; Burgstaller, S; Schreder, M; Tinchon, C; Pfeilstocker, M; Steinkirchner, S; Melchardt, T; Mitrovic, M; Girschikofsky, M; Lang, A; Krippl, P; Egle, A; Sliwa, T; Linkesch, W; Fridrik, MA; Greil, R Activity of Azacitidine in 26 Unselected, Consecutive CMML Patients Included in the Austrian Azacitidine Registry (AAR) of the AGMT-Study Group
BLOOD. 2011; 118(21): 747-747. [Poster]
Web of Science

 

** Scholz, C; Pinto, A; Linkesch, W; Linden, O; Viardto, A; Keller, U; Hess, G; Lerch, K; Frigeri, F; Frericks, B; Stroux, A; Pott, C; Pezzutto, A 90Yttrium Ibritumomab Tiuxetan as first line treatment for follicular lymphoma. 24 months follow up data from an international phase II clinical trial.
Onkologie. 2011; 34(6):270-270.-Jahrestagung der DÖuSGHO; SEP 30-OCT 04, 2011; Basel. [Poster]
Web of Science

 

** Zinke-Cerwenka, W; Rohn, A; Posch, U; Beham-Schmid, C; Linkesch, W; Wölfler, A; Sill, H Graft-versus-primary malignancy in patients with therapy-related myeloid neoplasms (t-MNs) undergoing reduced-intensity allogeneic hematopoietic stem cell transplantation (HSCT).
Onkologie. 2011; 34(6):274-274.-Jahrestagung der DÖuSGHO; SEP 30-OCT 04, 2011; Basel. [Poster]
Web of Science

 

2010

Originalarbeit (Zeitschrift)

** Gattermann, N; Finelli, C; Porta, MD; Fenaux, P; Ganser, A; Guerci-Bresler, A; Schmid, M; Taylor, K; Vassilieff, D; Habr, D; Domokos, G; Roubert, B; Rose, C; EPIC study investigators Deferasirox in iron-overloaded patients with transfusion-dependent myelodysplastic syndromes: Results from the large 1-year EPIC study.
Leuk Res. 2010; 34(9): 1143-1150. Doi: 10.1016/j.leukres.2010.03.009
Web of Science PubMed FullText FullText_MUG

 

** Schmidt, S; Wolf, D; Thaler, J; Burgstaller, S; Linkesch, W; Petzer, A; Fridrik, M; Lang, A; Agis, H; Valent, P; Krieger, O; Walder, A; Korger, M; Schlögl, E; Sliwa, T; Wöll, E; Mitterer, M; Eisterer, W; Pober, M; Gastl, G; on behalf of the ASHO CML registry First annual report of the Austrian CML registry.
Wien Klin Wochenschr. 2010; 122(19-20): 558-566. Doi: 10.1007/s00508-010-1450-x
Web of Science PubMed FullText FullText_MUG

 

** Worel, N; Panzer, S; Reesink, HW; Linkesch, W; Dickmeiss, E; Fischer-Nielsen, A; Holig, K; Stachel, D; Zimmermann, R; Holter, W; Coluccia, P; Brilhante, D; Watz, E; Sigle, JP; Gratwohl, A; Buser, A; Arslan, O; Regan, F; Edwards, M Transfusion policy in ABO-incompatible allogeneic stem cell transplantation
VOX SANG. 2010; 98(3): 455-467. Doi: 10.1111/j.1423-0410.2009.01292.x
Web of Science FullText FullText_MUG

 

Kurzbericht/Letter

** Reitter, S; Neumeister, P; Beham-Schmid, C; Emberger, W; Strunk, D; Brezinschek, R; Linkesch, W; Schmidt, HH A case of generalized MALT lymphoma with IgM paraproteinemia and peripheral blood involvement.
Ann Hematol. 2010; 89(2): 213-214. Doi: 10.1007/s00277-009-0787-6
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Zeitschrift)

** Aschauer, G; Greil, R; Linkesch, W; Pfeilstocker, M; Stauder, R; Thaler, J; Fiegl, M; Fridrik, M; Girschikofsky, M; Keil, F; Petzer, AL Results from the Austrian Project analysing retrospectively the use of Lenalidomide in patients with myelodysplatic syndroms (REALM)
ONKOLOGIE. 2010; 33: 224-224. [Poster]
Web of Science

 

** Bodner, C; Pichler, MM; Deutsch, AJ; Beham-Schmid, C; Linkesch, W; Sill, H; Wolfler, A IDH mutations in therapy-related and secondary AML evolving from myelodysplastic syndromes.
ONKOLOGIE. 2010; 33: 232-233.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OCT 1-5, 2010; Berlin, GERMANY. [Poster]
Web of Science

 

** Deutsch, AJA; Rinner, B; Knausz, H; Linkesch, W; Beham-Schmid, C; Neumeister, P Ccytosporone-B Induces NR4A1 Meditated Apoptosis In Aggressive Lymphoma Cells
BLOOD. 2010; 116(21): 208-209.
Web of Science

 

** Krieger, O; Machhemdl-Spandl, S; Hauser, H; Binder, M; Greinix, H; Eder, S; Kahls, P; Rabitsch, W; Nachbaur, D; Ludwig, H; Linkesch, W; Jaeger, G; Sill, H; Lindner, B Stem cell transplantation for MDS patients 1987-2008: data from the Austrian transplant registry (ASCTR)
BONE MARROW TRANSPLANT. 2010; 45: S180-S181. -36th Annual Meeting of the European Group for Blood and Marrow Transplantation; MAR 21-24, 2010; Vienna, AUSTRIA. [Poster]
Web of Science

 

** Langner, S; Staber, P; Linkesch, W; Strunk, D Long-term follow-up of minimal chronic graft-versus-host disease after reduced-intensity conditioning with pre-transplant low dose anti-thymocyte globulin in allogeneic stem cell transplantation
BONE MARROW TRANSPLANT. 2010; 45: S145-S145. - 36th Annual Meeting of the European Group for Blood and Marrow Transplantation; MAR 21-24, 2010; Vienna, AUSTRIA. [Poster]
Web of Science

 

** Neumeister, P; Schmidt, H; Linkesch, W; Pfeilstocker, M; Rohn, A SAFETY AND TOLERABILITY OF INTRATHECAL LIPOSOMAL CYTARABINE AS CNS PROPHYLAXIS IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
HAEMATOL-HEMATOL J. 2010; 95: 0621 -15th Congress of the European Hematology Association.; JUNE 10-13; Barcelona, SPAIN. [Poster]
Web of Science

 

** Pichler, M; Beham-Schmid, C; Lackner, K; Linkesch, W; Fickert, P; Emberger, W; Schmidt, H Cholestatic hepatitis due to diffuse liver infiltration by Acute myelogenous leukemia with inv(16)(p13;q22): A case report and review of the literature
ONKOLOGIE. 2010; 33: 141-141.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; Oct 1 -5, 2010; Berlin, Germany. [Poster]
Web of Science

 

** Reinisch, A; Hofmann, N; Obenauf, A; Karl, K; Rohde, E; Schallmoser, K; Thaler, D; Fruhwirth, M; Flicker, K; Linkesch, W; Speicher, M; Strunk, D STABLE VESSEL GENERATION TROUGH APPLICATION OF BLOOD-DERIVED ENDOTHELIAL COLONY FORMING PROGENITOR CELLS (ECFCS) AND MESENCHYMAL STROMAL/STEM CELLS (MSCS)
HAEMATOL-HEMATOL J. 15th Congress of the European Hematology Association. 2010; 95(s2):0509-220.-15th Congress of the European Hematology Association. ; JUN 10-13, 2010; Barcelona, SPAIN. [Oral Communication]
Web of Science

 

** Reinisch, A; Hofmann, NA; Obenauf, A; Kashofer, K; Rohde, E; Schallmoser, K; Thaler, D; Fruhwirth, M; Flicker, K; Linkesch, W; Speicher, M; Strunk, D Sustained vessel formation through co-transplantation of endothelial colony-forming progenitor cells with mesenchymal stromal cells
BONE MARROW TRANSPLANT. 2010; 45: S52-S52. -36th Annual Meeting of the European Group for Blood and Marrow Transplantation; MAR 21-24, 2010; Vienna, AUSTRIA. [Oral Communication]
Web of Science

 

** Reitter, S; Bauer, F; Jager, G; Linkesch, W; Langner, S Targeted inhibition of angiogenesis suggests a promising therapeutic option in Histiocytic Sarcoma
ONKOLOGIE. 2010; 33: 178-179. [Poster]
Web of Science

 

** Rohde, E; Schallmoser, K; Reinisch, A; Hofmann, NA; Pfeifer, T; Rechberger, G; Lanzer, G; Linkesch, W; Kratky, D; Strunk, D MAPK p38-dependent foam cell formation of myeloid cells after pro-angiogenic induction as a risk factor of therapeutic angiogenesis
BONE MARROW TRANSPLANT. 2010; 45: S283-S283. -36th Annual Meeting of the European Group for Blood and Marrow Transplantation; MAR 21-24, 2010; Vienna, AUSTRIA. [Poster]
Web of Science

 

** Schallmoser, K; Bartmann, C; Rohde, E; Bork, S; Guelly, C; Obenauf, A; Reinisch, A; Horn, P; Ho, A; Linkesch, W; Lanzer, G; Wagner, W; Strunk, D SENESCENCE-ASSOCIATED GENE EXPRESSION CHANGES IN MESENCHYMAL STROMAL/STEM CELLS
HAEMATOL-HEMATOL J. 2010; 95(s2):0249-110.-15th Congress of the European Hematology Association. ; JUN 10-13, 2010; Barcelona, SPAIN. [Poster]
Web of Science

 

** Schallmoser, K; Bartmann, C; Rohde, E; Bork, S; Guelly, C; Obenauf, AC; Reinisch, A; Hom, P; Ho, AD; Linkesch, W; Lanzer, G; Wagner, W; Strunk, D Replicative senescence-associated gene expression changes in mesenchymal stromal cells
BONE MARROW TRANSPLANT. 2010; 45: S281-S281. [Poster]
Web of Science

 

** Schallmoser K; Bartmann, C; Rohde E; Bork, S; Guelly, C; Obenauf, AC; Reinisch, A; Horn, P; Ho, AD; Linkesch, W; Lanzer, G; Wagner, W; Strunk, D Similarity of Replicative Senescence-Associated Gene Expression Changes in Mesenchymal Stromal Cells under Various Culture Conditions.
XXXIst International Congress of the ISBT in Joint Cooperation with the 43rd Congress of the DGTI2010; 99(1):481-482.-XXXIst International Congress of the ISBT in Joint Cooperation with the 43rd Congress of the DGTI; JUN 26-JUL 2, 2010; Berlin, GERMANY. [Poster]
Web of Science

 

** Schallmoser, K; Rohde, E; Obenauf, AC; Reinisch, A; Bartmann, C; Lanzer, G; Linkesch, W; Strunk, D Genomic Stability of Mesenchymal Stromal/Stem Cells After Long-Term Culture
TRANSFUSION. 2010; 50: 24A-24A.-AABB; 08.-12.10.2010; Baltimore, MD, USA. [Oral Communication]
Web of Science

 

** Schallmoser, K; Rohde, E; Reinisch, A; Obenauf, A; Bartmann, C; Lanzer, G; Linkesch, W; Strunk, D GENOMIC STABILITY IN LONG-TERM CULTURED MESENCHYMAL STROMAL/STEM CELLS
HAEMATOL-HEMATOL J. 2010; 95: 0247 [Poster]
Web of Science

 

** Schallmoser, K; Rohde, E; Reinisch, A; Obenauf, AC; Bartmann, C; Lanzer, G; Linkesch, W; Strunk, D Alteration of genomic stability in long-term cultured mesenchymal stromal cells
BONE MARROW TRANSPLANT. 2010; 45: S280-S280.-36th Annual Meeting of the European Group for Blood and Marrow Transplantation; MAR 21-24, 2010; Vienna, AUSTRIA. [Poster]
Web of Science

 

** Scholz, CW; Pinto, A; Linkesch, W; Linden, O; Viardot, A; Keller, U; Hess, G; Lerch, K; Frigeri, F; Arcamone, M; Frericks, B; Pott, C; Pezzutto, A 90Yttrium Ibritumomab Tiuxetan as First Line Treatment for Follicular Lymphoma, First Results from an International Phase II Clinical Trial
BLOOD. 2010; 116(21): 261-261. Doi: 10.1182/blood.V116.21.593.593
Web of Science FullText FullText_MUG

 

** Sormann, S; Bauer, F; Reitter, S; Pichler, M; Stranzl, T; Dekic, D; Linkesch, W Results from the Myeloma Registry of the University Hospital Graz
ONKOLOGIE. 2010; 33: 249-250. [Poster]
Web of Science

 

** Thaler, D; Fruthwirth, M; Reinisch, A; Schallmoser, K; Rohde, E; Hofmann, NA; Linkesch, W; Hartwig, U; Strunk, D Combined action of endothelial and mesenchymal niche cells to amplify haematopoietic progenitor expansion in a humanized system
BONE MARROW TRANSPLANT. 2010; 45: S53-S53. - 36th Annual Meeting of hte European Group for Blood and Marrow Transplantation; MAR 21-24, 2010; Vienna, AUSTRIA. [Oral Communication]
Web of Science

 

** Worel, N; Rosskopf, K; Agis, H; Nachbaur, D; Kasparu, H; Russ, G; Keil, F; Linkesch, W; Greinix, H PLERIXAFOR PLUS G-CSF CAN SUCCESSFULLY MOBILIZE CD34+CELLS FROM PATIENTS WHO HAVE PREVIOUSLY FAILED CHEMOTHERAPY AND/OR CYTOKINE MOBILIZATION: THE COMPASSIONATE USE EXPERIENCE IN AUSTRIA
VOX SANG. 2010; 99: 9-10. [Poster]
Web of Science

 

** Worel, N; Rosskopf, K; Nachbaur, D; Kasparu, H; Russ, G; Namberger, K; Leitner, G; Kalhs, P; Schogl, E; Witt, V; Greinix, H; Keil, F; Linkesch, W Plerixafor plus G-CSF can successfully mobilize CD34+cells from patients who have previously failed chemotherapy and/or cytokine mobilization: the compassionate use experience in Austria
BONE MARROW TRANSPLANT. 2010; 45: S318-S318. -36th Annual Meeting of the European Group for Blood and Marrow Transplantation; MAR 21-24, 2010; Vienna, AUSTRIA. [Poster]
Web of Science

 

** Zinke-Cerwenka, W; Stojakovic, T; Rohn, A; Ziegler, I; Emberger, W; Sipurzynski, S; Linkesch, W; Neumeister, P First-line treatment with bortezomib, doxorubicine and dexamethasone followed by autologous peripheral blood stem cell transplantation in newly diagnosed patients with multiple myeloma
BONE MARROW TRANSPLANT. 2010; 45(2):S149-S149.-36th Annual Meeting of the European Group for Blood and Marrow Transplantation; MAR 21-24, 2010; Vienna, AUSTRIA. [Poster]
Web of Science

 

2009

Originalarbeit (Zeitschrift)

** Finke, J; Bethge, WA; Schmoor, C; Ottinger, HD; Stelljes, M; Zander, AR; Volin, L; Ruutu, T; Heim, DA; Schwerdtfeger, R; Kolbe, K; Mayer, J; Maertens, JA; Linkesch, W; Holler, E; Koza, V; Bornhäuser, M; Einsele, H; Kolb, HJ; Bertz, H; Egger, M; Grishina, O; Socié, G; ATG-Fresenius Trial Group Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial.
Lancet Oncol. 2009; 10(9): 855-864. Doi: 10.1016/S1470-2045(09)70225-6
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Petrides, PE; Gisslinger, H; Steurer, M; Linkesch, W; Krumpl, G; Schuller, A; Widmann, R Pharmacokinetics, bioequivalence, tolerability, and effects on platelet counts of two formulations of anagrelide in healthy volunteers and patients with thrombocythemia associated with chronic myeloproliferation.
CLIN THER. 2009; 31(2): 386-398. Doi: 10.1016/j.clinthera.2009.02.008
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Reinisch, A; Hofmann, NA; Obenauf, AC; Kashofer, K; Rohde, E; Schallmoser, K; Flicker, K; Lanzer, G; Linkesch, W; Speicher, MR; Strunk, D Humanized large-scale expanded endothelial colony-forming cells function in vitro and in vivo.
Blood. 2009; 113(26): 6716-6725. Doi: 10.1182/blood-2008-09-181362 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Pressetext

 

Abstract (Zeitschrift)

** Deutsch, AJA; Beham-Schmid, C; Linkesch, W; Neumeister, P The Nuclear Orphan Receptors NR4A1 and NR4A3 as Putative Tumour Suppressor Genes in Aggressive Non-Hodgkin's Lymphomas.
Blood2009; 114(22):1158-1158.-51st ASH Annual Meeting of the American Society of Hematology ; Dec 5-8, 2009; New Orleans, LA. [Poster]
Web of Science

 

** Fruehwirth, M; Thaler, D; Reinisch, A; Schallmoser, K; Rohde, E; Hofmann, NA; Linkesch, W; Strunk, D Contribution of endothelial and mesenchymal niche cells to haematopoietic progenitor expansion in a humanised system.
BONE MARROW TRANSPLANT. 2009; 43: S188-S189.-35th Annual Meeting of the European Group for Blood and Marrow Transplantation; MAR 29-APR 01, 2009; Goteborg, SWEDEN. [Poster]
Web of Science

 

** Jurczak, W; Skotnicki, AB; Deptala, A; Windemuth-Kieselbach, C; Lorsbach, M; Bischof Delaloye, A; Cheolwon, S; Zinzani, P; Cacchione, R; Linkesch, W; d'Amore, F; Truemper, LH Consolidation with Radioimmunotherapy May Prolong Survival in First Remission of Mantle Cell Lymphoma Patients Uneligible for Stem Cell Transplantation, An Analysis of the International RIT-Network.
BLOOD2009; 114(22):1442-1442.-Fifty-first annual meeting of American Society of Hematology; DEC 5-8, 2009; New Orleans, Louisiana. [Poster]
Web of Science

 

** Reinisch, A; Hofmann, NA; Obenauf, A; Kashofer, K; Rohde, E; Schallmoser, K; Thaler, D; Fruehwirth, M; Flicker, K; Linkesch, W; Speicher, M; Strunk, D Vascular regeneration by adult blood-derived endothelial colony-forming cells expanded under animal serum-free conditions
BONE MARROW TRANSPLANT. 35th Annual Meeting of the European Group for Blood and Marrow Transplantation2009; 43(1):S19-S20.-35th Annual Meeting of the European Group for Blood and Marrow Transplantation; MAR 29-APR 01, 2009; Goteborg, SWEDEN. [Oral Communication]
Web of Science

 

** Schallmoser, K; Rohde, E; Reinisch, A; Obenauf, A; Bartmann, C; Lanzer, G; Linkesch, W; Strunk, D Evidence for genomic stability of bone marrow-derived MSCS after large-scale expansion in a humanised system.
BONE MARROW TRANSPLANT. 35th Annual Meeting of the European Group for Blood and Marrow Transplantation2009; 43(1):S187-S187.-35th Annual Meeting of the European Group for Blood and MarrowTransplantation; MAR 29-APR 01, 2009; Goteborg, SWEDEN. [Poster]
Web of Science

 

2008

Originalarbeit (Zeitschrift)

** Aigelsreiter, A; Leitner, E; Deutsch, AJ; Kessler, HH; Stelzl, E; Beham-Schmid, C; Beham, A; Krugmann, J; Dinges, HP; Linkesch, W; Neumeister, P Chlamydia psittaci in MALT lymphomas of ocular adnexals: the Austrian experience.
Leuk Res. 2008; 32(8): 1292-1294. Doi: 10.1016/j.leukres.2007.10.013
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Langner, S; Staber, PB; Schub, N; Gramatzki, M; Grothe, W; Behre, G; Rabitsch, W; Urban, C; Linkesch, W; Neumeister, P Palifermin reduces incidence and severity of oral mucositis in allogeneic stem-cell transplant recipients.
Bone Marrow Transplant. 2008; 42(4): 275-279. Doi: 10.1038/bmt.2008.157 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Ludwig, H; Auberger, T; Burghuber, OCh; Gnant, M; Hopfinger, G; Jäger, U; Keil, F; Kornek, G; Linkesch, W; Petru, E; Pirker, R; Pittermann, E; Reinthaller, A; Samonigg, H; Steger, G; Stockenhuber, F; Studnicka, M; Weiss, G; Zielinski, C The use of erythropoiesis-stimulating proteins in anemic patients with malignant diseases
Wien Klin Wochenschr. 2008; 120(15-16): 507-513. Doi: 10.1007/s00508-008-1007-4
Web of Science PubMed FullText FullText_MUG

 

** Schallmoser, K; Rohde, E; Reinisch, A; Bartmann, C; Thaler, D; Drexler, C; Obenauf, AC; Lanzer, G; Linkesch, W; Strunk, D Rapid large-scale expansion of functional mesenchymal stem cells from unmanipulated bone marrow without animal serum.
Tissue Eng Part C Methods. 2008; 14(3): 185-196. Doi: 10.1089/ten.tec.2008.0060
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Valent, P; Lion, T; Wolf, D; Sillaber, C; Agis, H; Petzer, A; Lang, A; Kalhs, P; Geissler, D; Greil, R; Linkesch, W; Burgstaller, S; Thaler, J; Gastl, G Diagnostic algorithms, monitoring, prognostication, and therapy in chronic myeloid leukemia (CML): a proposal of the Austrian CML platform.
WIEN KLIN WOCHENSCHR. 2008; 120(21-22): 697-709. Doi: 10.1007/s00508-008-1100-8
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Zinzani, PL; d'Amore, F; Bombardieri, E; Brammer, C; Codina, JG; Illidge, T; Jurczak, W; Linkesch, W; Morschhauser, F; Vandenberghe, E; Van Hoof, A Consensus conference: implementing treatment recommendations on yttrium-90 immunotherapy in clinical practice - report of a European workshop.
EUR J CANCER. 2008; 44(3): 366-373. Doi: 10.1016/j.ejca.2007.12.008
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Zeitschrift)

** Avivi, I; Canals, C; Niederwieser, D; Kanz, L; Finke, J; Greinix, H; Nagler, A; Vaernant, JP; Bregni, M; Haioun, C; Linkesch, W; Schwerdtfeger, R; Sureda, A Matched unrelated donor stem cell transplantation for patients with diffuse large cell B cell lymphoma: a retrospective analysis of 118 patients registered through the European Group for Blood and Marrow Transplantation (EBMT)
BONE MARROW TRANSPLANT. 2008; 41: S43-S43.-34 th Meeting of the EBMT; MARCH 30- APR 2, 2008; Florence, ITALY. [Keynote lecture]
Web of Science

 

** Finke, J; Bethge, WA; Schmoor, C; Ottinger, H; Stelljes, M; Zander, A; Volin, L; Heim, D; Schwerdtfeger, R, Kolbe, K; Mayer, J; Maertens, J, Linkesch, W, Holler, E, Koza, V, Bornhaeuser, M, Einsele, H; Kolb, HJ, Bertz, H; Egger, M; Grichina, O; Socie, G A Randomized Prospecitve Multicenter Phase III Trial Comparing Standard GvHD Prophylaxis with Cyclosporine and Methotrexate with Additional Pretransplant ATG Fresenius (ATG-F) in Allogeneic Stem Cell Transplantation from Matched Unrelated Donors
Blood. 2008; 112(11):28-29.-Fiftieth Annual Meeting of American Society of Hematology; Dec 6-9,2008; San Francisco, California. [Oral Communication]
Web of Science

 

** Frühwirth, M; Thaler, D; Reinisch, A; Schallmoser, K; Rohde, E; Hofmann, NA; Linkesch, W; Strunk, D Combined Action of Endothelial and Mesenchymal Niche Cells to Amplify Hematopoietic Progenitor Expansion in a Humanized System.
Fiftieth annual meeting abstracts2008; 112(11):840-840.-American Society of Hematology 50th Annual Meeting and Exposition; DEC 6-9, 2008; San Francisco, USA. [Oral Communication]
Web of Science

 

** Hohloch, K; Zinzani, PL; Linkesch,W; Deptala,A; Wojciech,J; Suh,C; Lorsbach, M; Windemuth-Kiesselbach, C; Trümper;LH Radioimmunotherapy is safe and effective in relapse after stem cell transplantation for B-cell Non Hodgkins Lymphoma, an analysis of the International RIT-Network
Blood. 2008; 112(11):1053-1053.-Fiftieth Annual Meeting of American Society of Hematology; Dec 6-9,2008; San Francisco, California. [Poster]
Web of Science

 

** Ludwig, H; Spicka, I; Linkesch, W; Greil, R; Kasparu, H; Gunsilius, E; Thaler, J; Drach, J; Kuhn, I; WEißmann, A; Hinke, A Double transplantation with Melphalan (200 mg/m²) compared with triple transplantation with intermediate dose Melphalan (100 mg/m²) in patients with multiple myeloma
Blood. 2008; 112(11):1139-1139.-Fiftieth Annual Meeting of American Society of Hematology; Dec 6-9,2008; San Francisco, California. [Poster]
Web of Science

 

** Nickelsen, M; Canals, C; Schmitz, N; Kyriakou,C; Engelhardt,M, Relander,T; Linkesch,W;Koza V; Meloni,G; Lopez-Guillermo;L; Indrac,K; Caballero,D; Wandt, H; Theorin,N; Glass,B; Sureda, A Patients with Mature T-Cell Lymphoma show high relapse rates after high dose therapy and autologous stem cell transplantation
Blood. 2008; 112(11):287-287.-Fiftieth Annual Meeting of American Society of Hematology; Dec 6-9,2008; San Francisco, California. [Oral Communication]
Web of Science

 

** Nickelsen, M; Canals,C; Schmitz S; Glass, B; Leyvraz S; Engelhard M, Koza, V; Relander T; Holowiecki J; Linkesch, W; Losonczy H; Meloni G; Briones J; Sureda, A; Mature T-Cell Lymphoma Patients show high relapse rates after high dose therapy followed by Autologous Transplantation.
. 2008; 19(4): 113-114. [Poster]
Web of Science

 

** Reinisch, A; Diwoky, C; Hofmann, N; Schallmoser, K; Linkesch, W; Stollberger, R; Strunk, D Molecular Imaging of Bone Marrow Stromal Cells Abstract only
Bone Marrow Transplantation2008; 41(1):S432-S432.-34th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT); MAR 30-APR 2, 2008; Florence, Italy. [Poster]
Web of Science

 

** Reinisch, A; Hofmann, NA; Obenauf, A; Kashofer, K; Rohde, E; Schallmoser, K; Thaler, D; Fruehwirth, M; Linkesch, W; Speicher, M; Strunk, D Making Functional Endothelial Progenitors: Humanized Large-scale Animal Serum-free Propagated Adult Blood-derived Endothelial Colony-forming Cells Assemble Stable Perfused Vessels In vivo.
Fiftieth Annual Meeting Abstracts2008; 112(11):659-659.-American Society of Hematology 50th Annual Meeting and Exposition; DEC 6-9, 2008; San Francisco, USA. [Poster]
Web of Science

 

** Reitter, S; Posch, U; Eibl, M; Sill, H; Linkesch, W; Zinke-Cerwenka, W NONMYELOABLATIVE ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH RICHTER SYNDROME: A REPORT OF TWO CASES
HAEMATOL-HEMATOL J. 2008; 93: 1410--13th Congress of the European-Hematology-Association; JUN 12-15, 2008; Copenhagen, DENMARK. [Poster]
Web of Science

 

** Reitter, S; Zinke-Cerwenka, W; Zebisch, A; Sormann, S; Sill, H; Linkesch, W Haematopoetic stem cell transplantation in CLL: promising results using allogeneic reduced intensity conditioning compared with an autologous setting
BONE MARROW TRANSPLANT. 2008; 41: S309-S310.-34th Meeting oif the EBMT; MARCH 30- APR 2, 2008; Florence, ITALY. [Poster]
Web of Science

 

** Schallmoser, K; Rohde, E; Reinisch, A; Obenauf, AC; Bartmann, C; Lanzer, G; Linkesch, W; Strunk, D Genomic stability and safety of MSCs after animal serum-free humanized clinical scale propagation.
Fiftieth annual meeting abstracts2008; 112(11):805-805.-American Society of Hematology 50th Annual Meeting and Exposition; DEC 6-9, 2008; San Francisco, USA. [Poster]
Web of Science

 

** Zinke-Cerwenka, W; Posch, U; Sill, H; Eibl, E; Linkesch, W FOLLOW-UP OF PATIENTS WITH MULTIPLE MYELOMA UNDERGOING AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION (PBSCT) FOLLOWED BY REDUCED-INTENSITY ALLOGENEIC PBSCT
HAEMATOL-HEMATOL J. 2008; 93: 1435 [Poster]
Web of Science

 

** Zinke-Cerwenka, W; Posch, U; Zebisch, A; Linkesch, W; Sill, H Results of umbilical cord blood transplantations in adults with high-risk haematologic malignancies
BONE MARROW TRANSPLANT. BONE MARROW TRANSPLANTATION.2008; 41: S158-S158.-34th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/24nd Meeting of the EBMT-Nurses-Group/7th Meeting of the EBMT-Data-Management-Group; MAR 30-APR 02, 2008; Florence, ITALY. [Poster]
Web of Science

 

** Zinke-Cerwenka, W; Stojakovic, T; Sill, H; Eibl, E; Linkesch, W PROMISING THERAPY RESPONSE IN MULTIPLE MYELOMA PATIENTS TREATED WITH INDUCTION CHEMOTHERAPY CONSISTING OF BORTEZOMIB, DOXORUBICIN AND DEXAMETHASONE FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANTATION
HAEMATOL-HEMATOL J. 2008; 93: 0222--13th Congress of the European-Hematology-Association; JUN 12-15, 2008; Copenhagen, DENMARK. [Poster]
Web of Science

 

** Zinke-Cerwenka, W; Stojakovic, T; Zebisch, A; Sill, H; Linkesch, W Promising results in multiple myeloma patients treated with induction chemotherapy consisting of bortezomib, doxorubicin and dexamethasone followed by autologous stem cell transplantation
BONE MARROW TRANSPLANT. 2008; 41: S185-S185.-34th Meeting of the EBMT; March 30- APR 2, 2008; [Poster]
Web of Science

 

Abstract (Konferenzband)

** Reinisch, A; Bartmann, C; Schallmoser, K; Rohde, E; Lanzer, G; Linkesch, W; Strunk, D Human platelet-derived factors regulate gene expression profile and function of human multipotent mesenchymal stromal cells.
. 2008; 41(1): S128-S128. [Poster]
Web of Science

 

** Schallmoser, K; Rohde, E; Reinisch, A; Obenauf, A; Speicher, M; Bartmann, C; Lanzer, G; Linkesch, W; Strunk, D Minimum requirements for fully humanised clinical scale propagation of multipotent mesenchymal stromal cells.
. 2008; 41(1): S314-S314. [Poster]
Web of Science

 

2007

Originalarbeit (Zeitschrift)

** Bartmann, C; Rohde, E; Schallmoser, K; Pürstner, P; Lanzer, G; Linkesch, W; Strunk, D Two steps to functional mesenchymal stromal cells for clinical application.
Transfusion. 2007; 47(8): 1426-1435. Doi: 10.1111/j.1537-2995.2007.01219.x
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Deutsch, AJ; Aigelsreiter, A; Staber, PB; Beham, A; Linkesch, W; Guelly, C; Brezinschek, RI; Fruhwirth, M; Emberger, W; Buettner, M; Beham-Schmid, C; Neumeister, P MALT lymphoma and extranodal diffuse large B-cell lymphoma are targeted by aberrant somatic hypermutation.
Blood. 2007; 109(8):3500-3504 Doi: 10.1182/blood-2006-06-030494 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Reinisch, A; Bartmann, C; Rohde, E; Schallmoser, K; Bjelic-Radisic, V; Lanzer, G; Linkesch, W; Strunk, D Humanized system to propagate cord blood-derived multipotent mesenchymal stromal cells for clinical application.
Regen Med. 2007; 2(4):371-382 Doi: 10.2217/17460751.2.4.371 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Rohde, E; Bartmann, C; Schallmoser, K; Reinisch, A; Lanzer, G; Linkesch, W; Guelly, C; Strunk, D Immune cells mimic the morphology of endothelial progenitor colonies in vitro.
Stem Cells. 2007; 25(7): 1746-1752. Doi: 10.1634/stemcells.2006-0833 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Schallmoser, K; Bartmann, C; Rohde, E; Reinisch, A; Kashofer, K; Stadelmeyer, E; Drexler, C; Lanzer, G; Linkesch, W; Strunk, D Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells.
Transfusion. 2007; 47(8): 1436-1446. Doi: 10.1111/j.1537-2995.2007.01220.x
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Scheipl, S; Leithner, A; Radl, R; Beham-Schmid, C; Ranner, G; Linkesch, W; Windhager, R Myeloid sarcoma presenting in muscle-tissue of the lower limb: unusual origin of a compartment-syndrome.
Am J Clin Oncol. 2007; 30(6):658-659 Doi: 10.1097/01.coc.0000189704.33839.f9 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Staber, PB; Vesely, P; Haq, N; Ott, RG; Funato, K; Bambach, I; Fuchs, C; Schauer, S; Linkesch, W; Hrzenjak, A; Dirks, WG; Sexl, V; Bergler, H; Kadin, ME; Sternberg, DW; Kenner, L; Hoefler, G The oncoprotein NPM-ALK of anaplastic large-cell lymphoma induces JUNB transcription via ERK1/2 and JunB translation via mTOR signaling.
Blood. 2007; 110(9):3374-3383 Doi: 10.1182/blood-2007-02-071258 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Kurzbericht/Letter

** Jäger, G; Quehenberger, F; Linkesch, W; Neumeister, P CHOP chemotherapy followed by Rituximab consolidation as first line treatment in patients with follicular lymphoma. Long-term follow-up of a phase 2 trial.
EUR J HAEMATOL. 2007; 78(5): 453-455. Doi: 10.1111/j.1600-0609.2007.00848.x
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Weingrill, E; Wölfler, A; Strunk, D; Linkesch, W; Sill, H; Liebmann, PM Roscovitine in B-chronic lymphocytic leukemia cells: high apoptosis-inducing efficacy and synergism with alemtuzumab independent of the patients' pretreatment status.
Haematologica. 2007; 92(9): 1286-1288. Doi: 10.3324/haematol.10680 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Zeitschrift)

** Aigelsreiter, A; Deutsch, AJA; Stelzl, E; Beham-Schmid, C; Beham, A; Linkesch, W; Schaider, H; Kessler, HH; Neumeister, P Different chemokine receptor expression profile in extragastric and gastric MALT-lymphomas
LAB INVEST. 2007; 87: 232A-232A. [Poster]
Web of Science

 

** Aigelsreiter, A; Deutsch, AJA; Stelzl, E; Beham-Schmid, C; Beham, A; Linkesch, W; Schaider, H; Kessler, HH; Neumeister, P Different chemokine receptor expression profile in extragastric and gastric MALT-lymphomas
MODERN PATHOL. 2007; 20: 232A-232A. [Poster]
Web of Science

 

** Bartmann, C; Schallmoser, K; Rohde, E; Reinisch, A; Guelly, C; Lanzer, G; Linkesch, W; Strunk, D Human platelet-derived factors induce differential gene expression in bone marrow mesenchymal stem cells
HAEMATOL-HEMATOL J. 2007; 92: 318-318.-12th Congress of the European Hematology Association; JUN 7-10, 2007; Vienna, AUSTRIA. [Poster]
Web of Science

 

** Deutsch, AJA; Aigelsreiter, A; Steinbauer, E; Linkesch, W; Beham-Schmid, C; Schaider, H; Neumeister, P Chemokine receptor expression profile in the model of parotid MALT lymphomagenesis: De novo expression of CXCR6.
BLOOD. 2007; 110(11):772A-772A.-49 th Annual Meeting of the American Society of Hematology; NOV 16, 2007; Atlanta, USA. [Poster]
Web of Science

 

** Fuchs, C; Vesely, P; Bambach, I; Schauer, S; Linkesch, W; Stemberg, DW; Hoefler, G; Staber, PB Identification of critical phosporylation sites within NPM-ALK that regulate JUNB mRNA translation
BLOOD. 2007; 110(11):1044A-1045A.-49 th Annual Meeting of the American Society of Hematology; NOV 8-11, 2007; Atlanta, Georgia, USA. [Poster]
Web of Science

 

** Langner, S; Staber, P; Schub, N; Gramatzki, M; Grothe, W; Behre, G; Rabitsch, W; Linkesch, W; Neumeister, P Palifermin in unrelated donor transplant recipients
HAEMATOL-HEMATOL J. 2007; 92: 172-173. [Poster]
Web of Science

 

** Langner, S; Staber, P; Strunk, D; Linkesch, W Decreased chronic GVHD rate after reduced intensity conditioning with low dose ATG in allogeneic hematopoietic SCT
HAEMATOL-HEMATOL J. 2007; 92: 220-220.-12th Congress of the European Hematology Association; JUN 7-10, 2007; Vienna, AUSTRIA. [Poster]
Web of Science

 

** Ludwig, H; Tothova, E; Hajek, R; Drach, J; Labar, B; Egyed, M; Spicka, I; Gisslinger, H; Greil, R; Fridrik, M; Zojer, N; Kuhn, I; Linkesch, W; Mistrik, M; Jaksic, B; Kusec, R; Hinke, A Thalidomide-dexamethasoneversus melphalan-prednisoloneas first line treatment in elderly patients with multiple myeloma: Second interim analysis
HAEMATOL-HEMATOL J. 2007; 92: 166-166. [Poster]
Web of Science

 

** Malischnik, C; Schallmoser, K; Rohde, E; Reinisch, A; Guelly, C; Lanzer, G; Linkesch, W; Strunk, D Gene expression profiling of human multipotent mesenchymal stromal cells
BONE MARROW TRANSPLANT. 2007; 39: S51-S51. [Oral Communication]
Web of Science

 

** Neumeister, PN; Pfeilstocker, M; Linkesch, W; Rohn, A Safety and tolerability of intrathecal liposomal cytarabine as cns prophylaxis in patients with acute lymphoblastic leukemia
HAEMATOL-HEMATOL J. 2007; 92: 8-9. [Poster]
Web of Science

 

** Petrides, PE; Gisslinger, H; Steurer, M; Linkesch, H; Krumpl, G; Schuller, A; Widmann, R Differences in tolerability of two commercial anagrelide formulations may be caused by differences in bioavailability
HAEMATOL-HEMATOL J. 2007; 92: 244-244. [Poster]
Web of Science

 

** Reinisch, A; Bartmann, C; Rohde, E; Schallmoser, K; Bielic-Radisic, V; Lanzer, G; Linkesch, W; Strunk, D Clinical scale propagation of functional cord blood stem cells in a humanized system
HAEMATOL-HEMATOL J. 2007; 92: 318-318.-12th Congress of the European Hematology Association; JUN 7-10, 2007; Vienna, AUSTRIA. [Poster]
Web of Science

 

** Reinisch, A; Malischnik, C; Rohde, E; Schallmoser, K; Bjelic-Radisic, V; Lanzer, G; Linkesch, W; Strunk, D Clinical scale expansion of human cord blood-derived multipotent stem cells in a new FBS-free system
BONE MARROW TRANSPLANT. 2007; 39: S132-S133. [Poster]
Web of Science

 

** Rohde, E; Bartmann, C; Schallmoser, K; Reinisch, A; Lanzer, G; Linkesch, W; Guelly, C; Strunk, D Immune cells mimic endothelial progenitor colonies
TRANSFUSION. 2007; 47(3):69A-69A.-American Association of Blood Banks (AABB) 60th Annual Meeting; OKT 20-23, 2007; Anaheim, California, USA. [Poster]
Web of Science

 

** Rohde, E; Bartmann, C; Schallmoser, K; Reinisch, A; Lanzer, G; Linkesch, W; Guelly, C; Strunk, D Immune cells mimic the morphology of endothelial progenitor colonies in vitro
HAEMATOL-HEMATOL J. 2007; 92: 315-315.-12th Congress of the European Hematology Association; JUN 7-10, 2007; Vienna, AUSTRIA. [Poster]
Web of Science

 

** Rohde, E; Malischnik, C; Schallmoser, K; Reinisch, A; Lanzer, G; Linkesch, W; Guelly, C; Strunk, D Immune cells mimic endothelial progenitor colonies
BONE MARROW TRANSPLANT. 2007; 39: S123-S123. [Poster]
Web of Science

 

** Rohn, A; Leitner, C; Brezinschek, RI; Sormann, S; Linkesch, W; Strunk, D Radioimmunotherapy as a promising therapeutic option in patients with relapsed or refractory CD20(+) non-Hodgkins lymphoma
HAEMATOL-HEMATOL J. 2007; 92: 278-278.-12th Congress of the European Hematology Association; JUN 7-10, 2007; Vienna, AUSTRIA. [Poster]
Web of Science

 

** Schallmoser, K; Bartmann, C; Rohde, E; Reinisch, A; Kashofer, K; Emberger, W; Lanzer, G; Linkesch, W; Strunk, D A novel system for highly efficient clinical scale propagation of human mesenchymal stem cells with human platelet lysate
HAEMATOL-HEMATOL J. 2007; 92: 317-318.-12th Congress of the European Hematology Association; JUN 7-10, 2007; Vienna, AUSTRIA. [Poster]
Web of Science

 

** Schallmoser, K; Malischnik, C; Rohde, E; Reinisch, A; Kashofer, K; Lanzer, G; Linkesch, W; Strunk, D Two steps to clinical multipotent mesenchymal stromal cells with human platelet lysate
BONE MARROW TRANSPLANT. 2007; 39: S110-S110. [Poster]
Web of Science

 

** Schallmoser, K; Reinisch, A; Bartmann, C; Rohde, E; Kashofer, K; Emberger, W; Lanzer, G; Linkesch, W; Strunk, D Animal serum-free clinical scale propagation of human MSC
TRANSFUSION. 2007; 47(3):28A-28A.-American Association of Blood Banks (AABB) 60th Annual Meeting; OKT 20-23, 2007; Anaheim, California, USA. [Oral Communication]
Web of Science

 

** Zinke-Cerwenka, W; Scheidl, S; Eibl, M; Posch, U; Linkesch, W Incidence of late-onset noninfectious pulmonary complications in allogeneic stem cell transplantation with non-myeloablative conditioning based on fludarabine/TBI or fludarabine/melphalan
BONE MARROW TRANSPLANT. 2007; 39: S295-S295. [Poster]
Web of Science

 

** Zinke-Cerwenka, W; Stojakovic, T; Schamagl, H; Wassertheurer, S; Linkesch, W Therapy response by decrease of free light chain concentration in multiple myeloma patients treated with bortezomib/doxorubicin/dexamethasone as first-line therapy
BLOOD. 2007; 110(11):278B-278B.-49th Annual Meeting of the American Society of Hematology; DEC 8-11, 2007; Atlanta, USA . Doi: 10.1182/blood.V110.11.4818.4818 [Poster]
Web of Science FullText FullText_MUG

 

2006

Originalarbeit (Zeitschrift)

** Rohde, E; Malischnik, C; Thaler, D; Maierhofer, T; Linkesch, W; Lanzer, G; Guelly, C; Strunk, D Blood monocytes mimic endothelial progenitor cells.
Stem Cells. 2006; 24(2): 357-367. Doi: 10.1634/stemcells.2005-0072 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Staber, PB; Noehammer, C; Dürkop, H; Schauer, S; Kenner, L; Linkesch, W; Hoefler, G mRNA expression patterns indicate CD30 mediated activation of different apoptosis pathways in anaplastic large cell lymphoma but not in Hodgkin's lymphoma.
Leuk Res. 2006; 30(3):343-348 Doi: 10.1016/j.leukres.2005.08.010
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Zebisch, A; Staber, PB; Delavar, A; Bodner, C; Hiden, K; Fischereder, K; Janakiraman, M; Linkesch, W; Auner, HW; Emberger, W; Windpassinger, C; Schimek, MG; Hoefler, G; Troppmair, J; Sill, H Two transforming C-RAF germ-line mutations identified in patients with therapy-related acute myeloid leukemia.
Cancer Res. 2006; 66(7):3401-3408 Doi: 10.1158/0008-5472.CAN-05-0115 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Kurzbericht/Letter

** Jager, G; Neumeister, P; Quehenberger, F; Wohrer, S; Linkesch, W; Raderer, M Prolonged clinical remission in patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type treated with cladribine: 6 year follow-up of a phase II trial.
ANN ONCOL. 2006; 17(11): 1722-1723. Doi: 10.1093/annonc/mdl126 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Zeitschrift)

** Aigelsreiter, A; Stelzl, E; Deutsch, A; Beham-Schmid, C; Beham, A; Lanzer, G; Linkesch, W; Kessler, H; Neumeister, P Association between Chlamydia psittaci infection and extranodal marginal zone B-cell lymphoma of mucosa associated lymphoid tissue (MALT)-lymphomas.
J CLIN ONCOL. 2006; 24(18):438S-438S.-ASCO; 2.-6. Juni 2006; Altlanta, USA. [Poster]
Web of Science

 

** Fruehwirth, M; Deutsch, AJA; Staber, PB; Aigelsreiter, A; Linkesch, W; Beham-Schimid, C; Neumeister, P Aberrant somatic hypermutation of follicular lymphoma transformed to diffuse large B-cell lymphoma.
BLOOD. 2006; 108(11): 683A-683A. Doi: 10.1182/blood.V108.11.2413.2413 [Poster]
Web of Science FullText FullText_MUG

 

** Langner, S; Staber, P; Radspieler, G; Triebl-Roth, K; Urban, C; Zinke-Cerwenka, W; Sill, H; Linkesch, W; Neumeister, P Palifermin reduces oral mucositis and enhances the recovery of intestinal mucosa measured by citrulline serum levels in allogeneic and autologous stem cell transplant recipients
BONE MARROW TRANSPLANT. 37: S73-S74.-32nd Annual Meeting of the European-Group-for-Blood-and-Morrow-Transplantation/22nd Meeting of the EBMT-Nures-Group/5th Meeting of the EMBT-Data-Management-Group; MAR 19-22, 2006; Hamburg, GERMANY. [Poster]
Web of Science

 

** Langner, S; Staber, PB; Zebisch, A; Zinke-Cerwenka, W; Sill, H; Linkesch, W; Greinix, H; Kalhs, P; Rabitsch, W; Neumeister, P Adding palifermin in allogeneic and autologous stem cell transplantation resulted in reduced oral mucositis and enhanced intestinal mucosal recovery measured by citrulline serum levels.
BLOOD. 2006; 108(11): 404B-404B. Doi: 10.1182/blood.V108.11.5251.5251 [Poster]
Web of Science FullText FullText_MUG

 

** Ludwig, H; Linkesch, W; Kasparu, H; Krieger, O; Spicka, I; Gastl, G; Greil, R; Drach, J; Thaler, J; Kuhn, I; Zojer, N; Hinke, A Prospective, randomized comparison between double mransplantation (T) with melphalan (200 mg/m(2)) and triple T with intermediate dose melphalan (100 mg/m(2)) in patients with multiple myeloma (an interim analysis).
BLOOD. 2006; 108(11): 878A-879A. Doi: 10.1182/blood.V108.11.3083.3083 [Poster]
Web of Science FullText FullText_MUG

 

** Malischnik, C; Rohde, E; Thaler, D; Linkesch, W; Lanzer, G; Strunk, D Preclinical protocol: two steps to propagate human MSC for therapeutic application
BONE MARROW TRANSPLANT. 2006; 37: S152-S152.-32nd Annual Meeting of the European-Group-for-Blood-and-Morrow-Transplantation/22nd Meeting of the EBMT-Nures-Group/5th Meeting of the EMBT-Data-Management-Group; MAR 19-22, 2006; Hamburg, GERMANY. [Oral Communication]
Web of Science

 

** Malischnik, C; Schallmoser, K; Rohde, E; Reinisch, A; Guelly, C; Lanzer, G; Linkesch, W; Strunk, D Human platelet-derived factors regulate mesenchymal stem cell gene expression.
BLOOD. 2006; 108(11): 142B-142B. [Poster]
Web of Science

 

** Rohde, E; Malischnik, C; Schallmoser, K; Reinisch, A; Lanzer, G; Linkesch, W; Guelly, C; Strunk, D Immune cells mimic endothelial progenitor colonies.
BLOOD. 2006; 108(11): 513A-513A. Doi: 10.1182/blood.V108.11.1811.1811 [Poster]
Web of Science FullText FullText_MUG

 

** Rohde, E; Malischnik, C; Thaler, D; Maierhofer, T; Linkesch, W; Lanzer, G; Guelly, C; Strunk, D Molecular mimicry: monocytes display endothelial cell related marker molecules
BONE MARROW TRANSPLANT. 2006; 37: S24-S24.-32nd Annual Meeting of the European-Group-for-Blood-and-Morrow-Transplantation/22nd Meeting of the EBMT-Nurses-Group/5th Meeting of the EMBT-Data-Management-Group; MAR 19-22, 2006; Hamburg, GERMANY. [Oral Communication]
Web of Science

 

** Schallmoser, K; Malischnik, C; Rohde, E; Reinisch, A; Guelly, C; Lanzer, G; Linkesch, W; Strunk, D Human mesenchymal stem cell therapy: Platelet lysate supports efficient preclinical expansion.
BLOOD. 2006; 108(11): 1042A-1042A. Doi: 10.1182/blood.V108.11.3649.3649 [Poster]
Web of Science FullText FullText_MUG

 

** Staber, PB; Vesely, P; Ott, R; Haq, N; Linkesch, W; Schauer, S; Hrzenjak, A; Kenner, L; Dirks, W; Kadin, ME; Sternberg, DW; Hoefler, G NPM-ALK fusion tyrosine kinase of anaplastic large cell lymphoma exerts its transforming potential by increasing translation of JUNB through mTOR and S6K1.
BLOOD. 2006; 108(11): 414A-415A. Doi: 10.1182/blood.V108.11.1428.1428 [Poster]
Web of Science FullText FullText_MUG

 

** Vesely, P; Staber, PB; Ott, R; Pinent, M; Linkesch, W; Schauer, S; Hrzenjak, A; Kadin, ME; Sternberg, DW; Hoefler, G NPM-ALK converts JUNB from a tumor suppressor to an oncogene.
BLOOD. 2006; 108(11): 419A-420A. Doi: 10.1182/blood.V108.11.1448.1448 [Poster]
Web of Science FullText FullText_MUG

 

** Zinke-Cerwenka, W; Eibl, M; Neumeister, P; Sill, H; Linkesch, W Late effects after autologous peripheral blood stem cell transplantation followed by reduced-intensity allogeneic peripheral blood stem cell transplantation in patients with multiple myeloma
BONE MARROW TRANSPLANT. ; 37: S113-S113.-32nd Annual Meeting of the European-Group-for-Blood-and-Morrow-Transplantation/22nd Meeting of the EBMT-Nures-Group/5th Meeting of the EMBT-Data-Management-Group; MAR 19-22, 2006; Hamburg, GERMANY. [Poster]
Web of Science

 

2005

Originalarbeit (Zeitschrift)

** Auner, HW; Zebisch, A; Ofner, P; Sill, H; Linkesch, W; Krause, R Evaluation of potential risk factors for early infectious complications after autologous peripheral blood stem cell transplantation in patients with lymphoproliferative diseases.
ANN HEMATOL. 2005; 84: 532-537. Doi: 10.1007/s00277-005-1025-5
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Fridrik, MA; Hausmaninger, H; Linkesch, W; Greil, R; Krieger, O; Baldinger, C; Klocker, J; Pont, J; Oberaigner, W Long-term results of dose density therapy in patients with aggressive lymphoma.
ANN HEMATOL. 2005; 84(4): 217-222. Doi: 10.1007/s00277-004-0936-x
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Jaeger, G; Linkesch, W; Temmel, W; Neumeister, P AntiCD20 monoclonal antibody-based radioimmunotherapy of relapsed chemoresistant aggressive post-transplantation B-lymphoproliferative disorder in heart-transplant recipient.
LANCET ONCOL. 2005; 6(8): 629-631. Doi: 10.1016/S1470-2045(05)70286-2 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Ludwig, H; Spicka, I; Klener, P; Greil, R; Adam, Z; Gisslinger, H; Tarkovács, G; Linkesch, W; Maniatis, A; Morant, R; Drach, J; Kuhn, I; Schuster, J; Hinke, A Continuous prednisolone versus conventional prednisolone with VMCP-interferon-alpha2b as first-line chemotherapy in elderly patients with multiple myeloma.
BRIT J HAEMATOL. 2005; 131(3): 329-337. Doi: 10.1111/j.1365-2141.2005.05779.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Nachbaur, D; Greinix, HT; Koller, E; Krieger, O; Linkesch, W; Kasparu, H; Pober, M; Hinterberger, W; Hausmaninger, H; Heistinger, M; Ulsperger, E; Karlhuber, S; Schwinger, W; Lindner, B Long-term results of autologous stem cell transplantation for Hodgkin's disease (HD) and low-/intermediate-grade B non-Hodgkin's lymphoma (NHL): a report from the Austrian Stem Cell Transplantation Registry (ASCTR).
Ann Hematol. 2005; 84(7):462-473 Doi: 10.1007/s00277-004-1003-3
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Pico, JL; Rosti, G; Kramar, A; Wandt, H; Koza, V; Salvioni, R; Theodore, C; Lelli, G; Siegert, W; Horwich, A; Marangolo, M; Linkesch, W; Pizzocaro, G; Schmoll, HJ; Bouzy, J; Droz, JP; Biron, P; Genito-Urinary Group of the French Federation of Cancer Centers (GETUG-FNCLCC), France; European Group for Blood and Marrow Transplantation (EBMT) A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumours.
Ann Oncol. 2005; 16(7):1152-1159 Doi: 10.1093/annonc/mdi228 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Staber, PB; Holub, R; Linkesch, W; Schmidt, H; Neumeister, P Fixed-dose single administration of Pegfilgrastim vs daily Filgrastim in patients with haematological malignancies undergoing autologous peripheral blood stem cell transplantation.
BONE MARROW TRANSPLANT. 2005; 35(9): 889-893. Doi: 10.1038/sj.bmt.1704927 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Strunk, D; Rohde, E; Lanzer, G; Linkesch, W Phenotypic characterization and preclinical production of human lineage-negative cells for regenerative stem cell therapy.
TRANSFUSION. 2005; 45: 315-326. Doi: 10.1111/j.1537-2995.2005.04056.x
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Wölfler, A; Erkeland, SJ; Bodner, C; Valkhof, M; Renner, W; Leitner, C; Olipitz, W; Pfeilstöcker, M; Tinchon, C; Emberger, W; Linkesch, W; Touw, IP; Sill, H A functional single-nucleotide polymorphism of the G-CSF receptor gene predisposes individuals to high-risk myelodysplastic syndrome.
Blood. 2005; 105(9):3731-3736 Doi: 10.1182/blood-2004-06-2094 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Zebisch, A; Linkesch, W; Sill, H Bedside RNA stabilizing kit systems for gene expression analysis of acute leukemias: influence of non-neoplastic white blood cells.
Leukemia. 2005; 19(4):685-685 Doi: 10.1038/sj.leu.2403713 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Kurzbericht/Letter

** Zebisch, A; Linkesch, W; Sill, H Bedside RNA stabilizing kit systems for gene expression analysis of acute leukemias: influence of non-neoplastic white blood cells.
LEUKEMIA. 2005; 19: 136-137. Doi: 10.1038/sj.leu.2403581 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Deutsch, A; Aigelsreiter, A; Beham-Schmid, C; Beham, A; Linkesch, W; Neumeister, P Aberrant somatic hypermutation in extranodal marginal zone B-cell lymphoma of MALT type.
BLOOD. 2005; 106: 125A-126A.-47th Annual Meeting of the American-Society-of-Hematology; DEC 10-13, 2005; Atlanta, GA.
Web of Science

 

** Ludwig, H; Drach, J; Tohova, E; Gisslinger, H; Jaksic, B; Linkesch, W; Hajek, R; Greil, R; Fridrik, M; Labar, B; Zojer, N Thalidomide-dexamethasone versus melphalan-prednisolone as first line treatment in elderly patients with multiple myeloma: An interim analysis.
J CLIN ONCOL 2005 23: 569S-569S.
Web of Science

 

** Ludwig, H; Drach, J; Tothova, E; Gisslinger, H; Linkesch, W; Jaksic, B; Fridik, M; Thaler, J; Lang, A; Hajek, R; Zojer, N; Greil, R; Kuhn, I; Hinke, A; Labar, B Thalidomide-dexamethasone versus melphalan-prednisolone as first line treatment in elderly patients with multiple myeloma: An interim analysis.
BLOOD 2005 106: 231A-231A.
Web of Science

 

** Malischnik, C; Rohde, E; Thaler, D; Vogel, B; Linkesch, W; Lanzer, G; Schaider, H; Strunk, D Low plating density boosts mesenchymal stem cell proliferation
BONE MARROW TRANSPLANT. 2005; 35: S139-S140.-31st Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation/21st Meeting of the EBMT-Nurses-Group/4th Meeting of the EBMT-Data-Management-Group; MAR 20-23, 2005; Prague, CZECH REPUBLIC.
Web of Science

 

** Rohde, E; Brulport, M; Malischnik, C; Thaler, D; Lanzer, G; Linkesch, W; Hengstler, J; Strunk, D Human lineage-negative cells for regenerative stem cell therapy
BONE MARROW TRANSPLANT. 2005; 35: S99-S100.-31st Annual Meeting of the European Group for Blood and Marrow Transplantation/21st Meeting of the EBMT Nurses Group/4th Meeting of the EBMT Data Management Group; MAR 20-23, 2005; Prague, CZECH REPUBLIC.
Web of Science

 

** Rohde, E; Malischnik, C; Linkesch, W; Lanzer, G; Strunk, D How to define endothelial progenitor cells in human blood?
BONE MARROW TRANSPLANT. 2005; 35: S78-S78.-31st Annual Meeting of the European Group for Blood and Marrow Transplantation/21st Meeting of the EBMT Nurses Group/4th Meeting of the EBMT Data Management Group; MAR 20-23, 2005; Prague, CZECH REPUBLIC.
Web of Science

 

** Thaler, D; Rohde, E; Malischnik, C; Linkesch, W; Lanzer, G; Strunk, D Environmental conditioning of CFU-EC by primed blood monocytes
BONE MARROW TRANSPLANT. 2005; 35: S115-S115.-31st Annual Meeting of the European Group for Blood and Marrow Transplantation/21st Meeting of the EBMT Nurses Group/4th Meeting of the EBMT Data Management Group; MAR 20-23, 2005; Prague, CZECH REPUBLIC.
Web of Science

 

** Zinke-Cerwenka, W; Neumeister, P; Eibl, M; Sill, H; Emberger, W; Wagner, T; Wolfler, A; Linkesch, W Planned sequential autologous/non-myeloablative allogeneic peripheral stem cell transplantation in patients with newly diagnosed high-risk multiple myeloma
BONE MARROW TRANSPLANT 2005 35: S387-S388.
Web of Science

 

2004

Originalarbeit (Zeitschrift)

** Auner, HW; Zebisch, A; Schimek, MG; Bodner, C; Hiden, K; Linkesch, W; Haas, OA; Beham-Schmid, C; Sill, H High expression of the sister-chromatid separation regulator and proto-oncogene hSecurin occurs in a subset of myeloid leukaemias but is not implicated in the pathogenesis of aneuploidy.
Leukemia. 2004; 18(2):303-308 Doi: 10.1038/sj.leu.2403235 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Eibl, M; Auner, HW; Zinke-Cerwenka, W; Sill, H; Dornbusch, HJ; Linkesch, W High-risk AML complicated by pulmonary aspergillosis: successful treatment with nonmyeloablative stem cell transplantation and long-term administration of voriconazole.
ANN HEMATOL. 2004; 83(2): 133-136. Doi: 10.1007/s00277-003-0782-2 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Jäger, G; Höfler, G; Linkesch, W; Neumeister, P Occurrence of a myelodysplastic syndrome (MDS) during first-line 2-chloro-deoxyadenosine (2-CDA) treatment of a low-grade gastrointestinal MALT lymphoma. Case report and review of the literature.
Haematologica. 2004; 89(4): ECR01-ECR01. (- Case Report) [OPEN ACCESS]
PubMed FullText Google Scholar

 

** Krause, R; Auner, HW; Gorkiewicz, G; Wölfler, A; Daxboeck, F; Linkesch, W; Krejs, GJ; Wenisch, C; Reisinger, EC Detection of catheter-related bloodstream infections by the differential-time-to-positivity method and gram stain-acridine orange leukocyte cytospin test in neutropenic patients after hematopoietic stem cell transplantation.
J CLIN MICROBIOL. 2004; 42(10): 4835-4837. Doi: 10.1128/JCM.42.10.4835-4837.2004 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Schmidt, HH; Renner, H; Linkesch, W Intrapleural instillation of rituximab for the treatment of malignant pleural effusions in NHL.
Haematologica. 2004; 89(11): ECR39-ECR39. (- Case Report) [OPEN ACCESS]
PubMed Google Scholar

 

** Schmidt, HH; Strehl, S; Thaler, D; Strunk, D; Sill, H; Linkesch, W; Jäger, U; Sperr, W; Greinix, HT; König, M; Emberger, W; Haas, OA RT-PCR and FISH analysis of acute myeloid leukemia with t(8;16)(p11;p13) and chimeric MOZ and CBP transcripts: breakpoint cluster region and clinical implications.
Leukemia. 2004; 18(6):1115-1121 Doi: 10.1038/sj.leu.2403353 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Schmitz, N; Ljungman, P; Cordonnier, C; Kempf, C; Linkesch, W; Alegre, A; Solano, C; Simonsson, B; Sonnen, R; Diehl, V; Fischer, T; Caballero, D; Littlewood, T; Noppeney, R; Schafhausen, P; Jost, L; Delabarre, F; Marcus, R Lenograstim after autologous peripheral blood progenitor cell transplantation: results of a double-blind, randomized trial.
BONE MARROW TRANSPLANT. 2004; 34(11): 955-962. Doi: 10.1038/sj.bmt.1704724 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Staber, PB; Linkesch, W; Zauner, D; Beham-Schmid, C; Guelly, C; Schauer, S; Sill, H; Hoefler, G Common alterations in gene expression and increased proliferation in recurrent acute myeloid leukemia.
Oncogene. 2004; 23(4):894-904 Doi: 10.1038/sj.onc.1207192 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Kurzbericht/Letter

** Strunk, D; Grube, R; Stadelmeyer, E; Linkesch, W Dendritic cell deficiency in early B cell chronic lymphocytic leukemia.
HAEMATOLOGICA. 2004; 89(1): 111-112. [OPEN ACCESS]
Web of Science PubMed

 

Abstract (Zeitschrift)

** Eibl, M; Auner, H; Zinke-Cerwenka, W; Sill, H; Linkesch, W Autologous stem cell transplantation with alemtuzumab as part of the conditioning for B-cell prolymphocytic leukaemia
BONE MARROW TRANSPLANT 2004 33: S290-S290.
Web of Science

 

** Eibl, M; Zinke-Cerwenka, W; Neumeister, P; Wolfler, A; Sill, H; Linkesch, W Autologous stem cell transplantation for multiple myeloma in elderly patients
BONE MARROW TRANSPLANT 2004 33: S357-S357.
Web of Science

 

** Ludwig, H; Zojer, N; Linkesch, W; Kahls, P; Krieger, O; Greinix, HT; Hinterberger, W; Pittermann, E; Bauernhofer, T; Gastl, G Results of autologous transplantation for multiple myeloma (MM) in Austria. An analysis based on data from the Austrian Stem Cell Transplantation (ASCT) Registry
J CLIN ONCOL 2004 22: 596S-596S.
Web of Science

 

** Neumeister, P; Holub, R; Staber, PB; Linkesch, W Pegfilgrastim shows safety and efficacy similar to filgrastim in patients undergoing autologous stem cell transplantation for hematological malignancies.
BLOOD 2004 104: 327A-327A. Doi: 10.1182/blood.V104.11.1156.1156
Web of Science FullText FullText_MUG

 

** Rohde, E; Thaler, D; Lanzer, G; Linkesch, W; Strunk, D Human lineage-negative cells for regenerative stem cell therapy
BONE MARROW TRANSPLANT 2004 33: S171-S172.
Web of Science

 

** Staber, PB; Linkesch, W; Schauer, S; Moser, G; Kadin, ME; Dirks, W; Hoefler, G Genes regulated by NPM-ALK fusion kinase play a key role in the activation of AP-1 transcription factors.
BLOOD 2004 104: 74A-74A. Doi: 10.1182/blood.V104.11.245.245
Web of Science FullText FullText_MUG

 

** Zebisch, A; Staber, PB; Fischereder, K; Bodner, C; Hiden, K; Linkesch, W; Auner, HW; Emberger, W; Windpassinger, C; Schimek, MG; Hoefler, G; Troppmair, J; Sill, H Two novel activating germline mutations of the C-RAF proto-oncogene predisposing to solid tbmors and therapy-related acute myeloid leukemia.
BLOOD 2004 104: 920A-920A. Doi: 10.1182/blood.V104.11.3370.3370
Web of Science FullText FullText_MUG

 

** Zinke-Cerwenka, W; Eibl, M; Sill, H; Hofler, G; Staber, P; Linkesch, W Continuous molecular response after discontinuation of imatinib mesylate following relapse after non-myeloablative allogeneic stem cell transplantation for CML
BONE MARROW TRANSPLANT 2004 33: S348-S348.
Web of Science

 

2003

Originalarbeit (Zeitschrift)

** Auner, HW; Tinchon, C; Linkesch, W; Tiran, A; Quehenberger, F; Link, H; Sill, H Prolonged monitoring of troponin T for the detection of anthracycline cardiotoxicity in adults with hematological malignancies.
Ann Hematol. 2003; 82(4):218-222 Doi: 10.1007/s00277-003-0615-3
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Kühr, T; Burgstaller, S; Apfelbeck, U; Linkesch, W; Seewann, H; Fridrik, M; Michlmayr, G; Krieger, O; Lutz, D; Lin, W; Pont, J; Köck, L; Abbrederis, K; Baldinger, C; Buder, R; Geissler, D; Hausmaninger, H; Lang, A; Zabernigg, A; Duba, C; Hilbe, W; Eisterer, W; Fiegl, M; Greil, R; Gastl, G; Thaler, J; Austrian CML Study Group A randomized study comparing interferon (IFN alpha) plus low-dose cytarabine and interferon plus hydroxyurea (HU) in early chronic-phase chronic myeloid leukemia (CML).
Leuk Res. 2003; 27(5):405-411 Doi: 10.1016%2FS0145-2126%2802%2900223-0
Web of Science PubMed FullText FullText_MUG

 

** Mikosch, P; Gallowitsch, HJ; Zinke-Cerwenka, W; Heinisch, M; Pipam, W; Eibl, M; Kresnik, E; Unterweger, O; Linkesch, W; Lind, P Accuracy of whole-body 18F-FDP-PET for restaging malignant lymphoma.
Acta Med Austriaca. 2003; 30(2):41-47 Doi: 10.1046%2Fj.1563-2571.2003.03003.x
Web of Science PubMed FullText FullText_MUG

 

** Schmidt, HH; Pirc-Danoewinata, H; Linkesch, W; Strunk, D; Wieser, R inv(3)(q21q26) in AML/MDS: Monitoring of the malignant clone with interphase FISH.
Haematologica. 2003; 88(12): ECR38-ECR38. (- Case Report) [OPEN ACCESS]
PubMed

 

** Staber, PB; Brezinschek, R; Linkesch, W; Sill, H; Neumeister, P Durable molecular response to imatinib mesylate following nonmyeloablative allogeneic stem-cell transplantation for persisting myeloid blast crisis in chronic myeloid leukemia.
Haematologica. 2003; 88(8):ECR29-ECR29 (- Case Report) [OPEN ACCESS]
PubMed Google Scholar

 

Kurzbericht/Letter

** Wölfler, A; Bauer, F; Zollner, G; Weber, K; Sill, H; Linkesch, W Fatal sepsis after thalidomide/dexamethasone treatment in two patients with multiple myeloma.
Haematologica. 2003; 88(4): ELT12-ELT12. (- Case Report) [OPEN ACCESS]
PubMed Google Scholar

 

Abstract (Zeitschrift)

** Dornbusch, HJ; Benesch, M; Eibl, M; Lackner, H; Linkesch, W; Schwinger, W; Sovinz, P; Strenger, V; Urban, CE Successful management of invasive pulmonary aspergillosis (IPA) in two patients with high risk acute leukemia by combined antifungal treatment and reduced intensity conditioning (RIC) stem cell transplantation (SCT).
BLOOD 2003 102: 441B-441B.
Web of Science

 

** Höfler, G; Staber, PB; Beham-Schmid, C; Guelly, C; Schauer, S; Linkesch, W Increased proliferation rate and activation of the B-RAF/MEK/erk pathway at relapse of acute myeloid leukemia
LAB INVEST 2003 83: 235A-236A.
Web of Science

 

** Höfler, G; Staber, PB; Beham-Schmid, C; Guelly, C; Schauer, S; Linkesch, W Increased proliferation rate and activation of the B-RAF/MEK/Erk pathway at relapse of acute myeloid leukemia
MODERN PATHOL 2003 16: 235A-236A.
Web of Science

 

** Kuhr, T; Apfelbeck, U; Linkesch, W; Mistrik, M; Tothova, E; Koza, V; Lutz, D; Vorlieek, J; Cernelc, P; Bernhart, M; Lin, W; Hausmaninger, H; Greil, R; Gastl, G; Michlmayr, G; Thaler, J Treatment of newly-diagnosed CML patients with interferon alpha and continuous versus intermittent cytarabin-ocfosfat (YNK01): A randomized Central European Leukemia Study.
BLOOD 2003 102: 311B-311B.
Web of Science

 

** Rohde, E; Lanzer, G; Linkesch, W; Strunk, D Immunophenotypic analysis and preclinical GMP-grade production of human lineage-negative cells for regenerative stem cell therapy.
BLOOD 2003 102: 463A-463A.
Web of Science

 

** Rohde, E; Lanzer, G; Linkesch, W; Strunk, D Characterization of human lineage-negative cells for regenerative stem cell therapy
BONE MARROW TRANSPLANT. 2003; 31: S203-S203.
Web of Science

 

** Rohde, E; Lanzer, G; Linkesch, W; Strunk, D Prevalence of CD7(+) cells in CD34(-)/Lin(-) human hematopoietic stem cell fractions
TRANSFUSION 2003 43: 52A-53A.
Web of Science

 

** Rosskopf, K; Sipurzynski, S; Gilli, R; Posch, U; Olipitz, W; Linkesch, W; Gehrer, M; Wagner, T; Lanzer, G Marked reduction of bacterial contamination rate in peripheral blood progenitor cell concentrates after installation of a labaratory according to GMP
BONE MARROW TRANSPLANT. 2003; 31: S200-S200.
Web of Science

 

** Staber, PB; Neumeister, P; Duerkop, H; Schauer, S; Linkesch, W; Hoefler, G CD30 induced cell death in anaplastic large cell lymphoma involves perforin/granzyme cell death pathway and the caspase dependent death receptors TNFR-1 and FAS/APO-1.
BLOOD 2003 102: 885A-885A.
Web of Science

 

** Wölfler, A; Erkeland, S; Leitner, C; Olipitz, W; Bodner, C; Wagner, T; Linkesch, W; Touw, IP; Sill, H A functional polymorphism of the granulocyte colony-stimulating factor receptor is associated with increased risk of myelodysplastic syndrome.
BLOOD 2003 102: 915A-916A.
Web of Science

 

2002

Originalarbeit (Zeitschrift)

** Auner, HW; Sill, H; Mulabecirovic, A; Linkesch, W; Krause, R Infectious complications after autologous hematopoietic stem cell transplantation: comparison of patients with acute myeloid leukemia, malignant lymphoma, and multiple myeloma.
ANN HEMATOL 2002 81: 374-377. Doi: 10.1007/s00277-002-0484-1
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Auner, HW; Tinchon, C; Brezinschek, RI; Eibl, M; Sormann, S; Maizen, C; Linkesch, W; Schmon-Kampel, R; Quehenberger, F; Tiran, A; Sill, H Monitoring of cardiac function by serum cardiac troponin T levels, ventricular repolarisation indices, and echocardiography after conditioning with fractionated total body irradiation and high-dose cyclophosphamide.
Eur J Haematol. 2002; 69(1):1-6 Doi: 10.1034%2Fj.1600-0609.2002.01661.x
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Beham-Schmid, C; Apfelbeck, U; Sill, H; Tsybrovsky, O; Höfler, G; Haas, OA; Linkesch, W Treatment of chronic myelogenous leukemia with the tyrosine kinase inhibitor STI571 results in marked regression of bone marrow fibrosis.
Blood. 2002; 99(1):381-383 Doi: 10.1182/blood.V99.1.381 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Greinix, HT; Nachbaur, D; Krieger, O; Eibl, M; Knöbl, P; Kalhs, P; Lutz, D; Linkesch, W; Niederwieser, D; Hinterberger, W; Lechner, K; Rosenmayr, A; Gritsch, B Factors affecting long-term outcome after allogeneic haematopoietic stem cell transplantation for acute myelogenous leukaemia: a retrospective study of 172 adult patients reported to the Austrian Stem Cell Transplantation Registry.
Br J Haematol. 2002; 117(4):914-923 Doi: 10.1046/j.1365-2141.2002.03532.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Hilbe, W; Kühr, T; Apfelbeck, U; Fridrik, M; Seewann, H; Stöger, M; Linkesch, W; Pont, J; Baldinger, C; Hartner, E; Bernhart, M; Geissler, D; Krieger, O; Lang, A; Lin, W; Ludwig, H; Duba, C; Greil, R; Gast, G; Thaler, J Dose escalation of ara-c may improve response rates in a subgroup of chronic myeloid leukemia patients with poor response to interferon-alpha and low-dose ara-C.
LEUK LYMPHOMA. 2002; 42(6): 1283-1288. Doi: 10.1080%2F10428190127503
Web of Science PubMed FullText FullText_MUG

 

** Jäeger, G; Neumeister, P; Brezinschek, R; Höfler, G; Quehenberger, F; Linkesch, W; Sill, H Rituximab (anti-CD20 monoclonal antibody) as consolidation of first-line CHOP chemotherapy in patients with follicular lymphoma: a phase II study.
EUR J HAEMATOL 2002 69: 21-26. Doi: 10.1034%2Fj.1600-0609.2002.01692.x
Web of Science PubMed FullText FullText_MUG

 

** Jäger, G; Neumeister, P; Brezinschek, R; Hinterleitner, T; Fiebiger, W; Penz, M; Neumann, HJ; Mlineritsch, B; DeSantis, M; Quehenberger, F; Chott, A; Beham-Schmid, C; Höfler, G; Linkesch, W; Raderer, M Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type with cladribine: a phase II study.
J Clin Oncol. 2002; 20(18):3872-3877 Doi: 10.1200/JCO.2002.05.117 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Olipitz, W; Hopfinger, G; Aguiar, RC; Gunsilius, E; Girschikofsky, M; Bodner, C; Hiden, K; Linkesch, W; Hoefler, G; Sill, H Defective DNA-mismatch repair: a potential mediator of leukemogenic susceptibility in therapy-related myelodysplasia and leukemia.
Genes Chromosomes Cancer. 2002; 34(2):243-248 Doi: 10.1002/gcc.10059
Web of Science PubMed FullText FullText_MUG

 

** Petzer, AL; Hochenburger, E; Haun, M; Duba, HCh; Grünewald, K; Hoflehner, E; Sill, H; Linkesch, W; Gastl, G; Gunsilius, E High-dose hydroxyurea plus G-CSF mobilize BCR-ABL-negative progenitor cells (CFC, LTC-IC) into the blood of newly diagnosed CML patients at any time of hematopoietic regeneration.
J HEMATOTHER STEM CELL RES 2002 11: 293-300. Doi: 10.1089/152581602753658475
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Tinchon, C; Auner, HW; Beham-Schmid, C; Aberle, SW; Sill, H; Linkesch, W Symptomatic Epstein-Barr virus reactivation in a patient with acute myeloid leukaemia and treatment with the monoclonal anti-CD20 antibody rituximab.
EUR J HAEMATOL 2002 69: 50-53. Doi: 10.1034%2Fj.1600-0609.2002.02740.x (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

** Worel, N; Biener, D; Kalhs, P; Mitterbauer, M; Keil, F; Schulenburg, A; Höcker, P; Dieckmann, K; Fischer, G; Rosenmayr, A; Linkesch, W; Hinterberger, W; Lechner, K; Greinix, HT Long-term outcome and quality of life of patients who are alive and in complete remission more than two years after allogeneic and syngeneic stem cell transplantation.
Bone Marrow Transplant. 2002; 30(9):619-626 Doi: 10.1038/sj.bmt.1703677 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Kurzbericht/Letter

** Auner, HW; Wölfler, A; Beham-Schmid, C; Strunk, D; Linkesch, W; Sill, H Restoration of erythropoiesis by rituximab in an adult patient with primary acquired pure red cell aplasia refractory to conventional treatment.
BRIT J HAEMATOL 2002 116: 727-728. Doi: 10.1046%2Fj.1365-2141.2002.3317_3.x (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Zeitschrift)

** Baccarani, M; Durrant, S; Linkesch, W; Lechner, K; Cooper, M; Coutre, S; Leopold, L; White, B; Richie, M; Berger, M Preliminary report of a phase 2 study of the safety and efficacy of gemtuzumab ozogamicin (Mylotarg (R)) given in combination with cytarabine in patients with acute myeloid leukemia.
BLOOD 2002 100: 1322-1322.
Web of Science PubMed

 

** Kuehr, T; Burgstaller, S; Apfelbeck, U; Linkesch, W; Mistrik, M; Tothova, E; Koza, V; Greil, R; Michlmayr, G; Lutz, W; Thaler, J Interferon alpha in combination with intermittent versus continuous YNK01 in patients with CML in early chronic phase: Preliminary results of a randomized phase III study.
BLOOD 2002 100: 328B-328B.
Web of Science

 

** Marcus, R; Linkesch, W; Solano, S; Alegre, A; Ljungman, P; Simonsson, B; Fischer, T; Soufi-Mahjoubi, R; Schmitz, N Effect of lenograstim on infections after high-dose chemotherapy and autologous peripheral stem cell transplantation
BONE MARROW TRANSPLANT. 2002; 29: S36-S36.
Web of Science

 

** Rosskopf, K; Wagner, T; Schallmoser, K; Eibl, M; Brezinschek, R; Linkesch, W; Lanzer, G Clots In cryopreserved autologous peripheral blood stem cell concentrates (Pbsc) at the time of thawing - Possible causes and prophylactic strategies
BONE MARROW TRANSPLANT. 2002; 29: S203-S203.
Web of Science

 

** Staber, PB; Hoefler, G; Beham-Schmid, C; Guelly, C; Schauer, S; Linkesch, W Increased proliferation rate in acute myeloid leukemia blasts at relapse due to activation of the B-Raf/MEK/Erk pathway.
BLOOD 2002 100: 330A-330A.
Web of Science

 

** Zinke-Cerwenka, W; Eibl, M; Beham-Schmid, C; Sormann, S; Neumeister, P; Linkesch, W Autologous stem cell transplantation in patients with peripheral T-cell lymphomas
BONE MARROW TRANSPLANT. 2002; 29: S88-S88.
Web of Science

 

Originalarbeit (Konferenzband)

** Strunk, D; Grube, R; Stadelmeyer, E; Chraust, S; Linkesch, W Impaired dendritic cell function in B-CLL
. 7TH ANNUAL MEETING OF THE EUROPEAN HAEMATOLOGY ASSOCIATION; 205-209. (ISBN: 88-323-2606-X) ( Presented at: 7th Annual Meeting of the European-Haematology-Association, FLORENCE, ITALY, JUN 06-09, 2002)
Web of Science

 

Kommentar

** Wölfler, A; Abuja, PM; Linkesch, W; Schauenstein, K; Liebmann, PM Questionable benefit of melatonin for antioxidant pharmacologic therapy.
J Clin Oncol. 2002; 20(19):4127-4128 Doi: 10.1200/JCO.2002.99.158 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2001

Originalarbeit (Zeitschrift)

** Boogaerts, M; Winston, DJ; Bow, EJ; Garber, G; Reboli, AC; Schwarer, AP; Novitzky, N; Boehme, A; Chwetzoff, E; De Beule, K; Itraconazole Neutropenia Study Group (incl. Linkesch, W) Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy. A randomized, controlled trial.
Ann Intern Med. 2001; 135(6): 412-422. Doi: 10.7326/0003-4819-135-6-200109180-00010 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Halwachs-Baumann, G; Wilders-Truschnig, M; Enzinger, G; Eibl, M; Linkesch, W; Dornbusch, HJ; Santner, BI; Marth, E; Kessler, HH Cytomegalovirus diagnosis in renal and bone marrow transplant recipients: the impact of molecular assays.
J Clin Virol. 2001; 20(1-2):49-57 Doi: 10.1016%2FS1386-6532%2800%2900155-4
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Hochhaus, A; Kreil, S; Corbin, A; La Rosée, P; Lahaye, T; Berger, U; Cross, NC; Linkesch, W; Druker, BJ; Hehlmann, R; Gambacorti- Passerini, C; Corneo, G; D'Incalci, M Roots of clinical resistance to STI-571 cancer therapy.
Science. 2001; 293(5538):2163-2163 Doi: 10.1126/science.293.5538.2163a [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Linkesch, W; Weger, M; Eder, I; Auner, HW; Pernegg, C; Kraule, C; Czejka, MJ Long-term pharmacokinetics of doxorubicin HCl stealth liposomes in patients after polychemotherapy with vinorelbine, cyclophosphamide and prednisone (CCVP).
Eur J Drug Metab Pharmacokinet. 2001; 26(3):179-184 Doi: 10.1007/BF03190394
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Mitterbauer, M; Neumeister, P; Kalhs, P; Brugger, S; Fischer, G; Dieckmann, K; Hoecker, P; Hinterberger, W; Linkesch, W; Simonitsch, I; Jaeger, U; Lechner, K; Mannhalter, C; Mitterbauer, G; Greinix, HT Long-term clinical and molecular remission after allogeneic stem cell transplantation (SCT) in patients with poor prognosis non-Hodgkin's lymphoma.
Leukemia. 2001; 15(4):635-641 Doi: 10.1038/sj.leu.2402053 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Neumeister, P; Eibl, M; Zinke-Cerwenka, W; Scarpatetti, M; Sill, H; Linkesch, W Hepatic veno-occlusive disease in two patients with relapsed acute myeloid leukemia treated with anti-CD33 calicheamicin (CMA-676) immunoconjugate.
Ann Hematol. 2001; 80(2):119-120 Doi: 10.1007%2Fs002770000239 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Neumeister, P; Jaeger, G; Eibl, M; Sormann, S; Zinke, W; Linkesch, W Amifostine in combination with erythropoietin and G-CSF promotes multilineage hematopoiesis in patients with myelodysplastic syndrome.
Leuk Lymphoma. 2001; 40(3-4):345-349 Doi: 10.3109/10428190109057933
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Kurzbericht/Letter

** Auner, HW; Tinchon, C; Quehenberger, F; Linkesch, W; Sill, H Troponins in prediction of cardiotoxic effects.
Lancet. 2001; 357(9258):808-808 Doi: 10.1016/S0140-6736(05)71241-1
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Apfelbeck, U; Eibl, M; Hoefler, G; Linkesch, W High-dose therapy and peripheral blood progenitor cell transplantation in elderly patients
BONE MARROW TRANSPLANT. 2001; 27: S315-S315.
Web of Science

 

** Auner, HW; Tinchon, C; Brezinschek, RI; Eibl, M; Sormann, S; Maizen, C; Linkesch, W; Schmon-Kampel, R; Sill, H Serum cardiac troponin T (cTnT) levels, ventricular repolarization indices and echocardiographic parameters after fractionated total body irradiation and high-dose cyclophosphamide (fTBI/Cy).
BLOOD 2001 98: 5138-5138.
Web of Science

 

** Eibl, M; Zinke-Cerwenka, W; Sormann, S; Apfelbeck, U; Linkesch, W Are CMV negative donors a special risk factor for CMV positive stem cell transplant recipients?
BONE MARROW TRANSPLANT. 2001; 27: S153-S153.
Web of Science

 

** Fridrik, MA; Hausmaninger, H; Linkesch, W; Greil, R; Michlmayr, G; Krieger, O; Baldinger, C; Klocker, J; Pont, J; Radaszkiewicz, T Long term results with a dose density therapy for aggressive non-Hodgkin's lymphoma. A study of the ARGE medikamentoese tumortherapie.
BLOOD 2001 98: 135A-135A.
Web of Science

 

** Greinix, HT; Nachbaur, D; Krieger, O; Eibl, M; Kalhs, P; Lutz, D; Linkesch, W; Niederwieser, D; Rosenmayr, A; Gritsch, B Factors impacting leukemia-free and overall survival of patients with acute myelogenous leukemia after allogeneic stem cell transplantation: report of the Austrian stem cell transplantation registry
BONE MARROW TRANSPLANT. 2001; 27: S81-S81.
Web of Science

 

** Stadelmeyer, E; Grube, R; Chraust, S; Linkesch, W; Strunk, D Alteration of dendritic cell function in B-CLL.
BLOOD 2001 98: 4891-4891.
Web of Science

 

** Zinke-Cerwenka, W; Eibl, M; Sormann, S; Neumeister, P; Linkesch, W Comparison of central venous catheters versus implantable intravenous devices in patients undergoing stem cell transplantation
BONE MARROW TRANSPLANT. 2001; 27: S311-S311.
Web of Science

 

Kommentar

** Auner, HW; Tinchon, C; Linkesch, W; Halwachs-Baumann, G; Sill, H Correspondence re: O. J. Arola et al., acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis. Cancer Res., 60: 1789-1792, 2000.
Cancer Res. 2001; 61(5):2335-2336 [OPEN ACCESS]
Web of Science PubMed FullText

 

2000

Originalarbeit (Zeitschrift)

** Apfelbeck, U; Hoefler, G; Neumeister, P; Fonatsch, C; Linkesch, W; Sill, H Extramedullary T cell lymphoblastic transformation of chronic myeloid leukaemia successfully treated with matched unrelated donor bone marrow transplantation.
BONE MARROW TRANSPLANT 2000 26: 1111-1112. Doi: 10.1038/sj.bmt.1702665 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Greinix, HT; Linkesch, W; Seifert, M; Kubista, E; Czerwenka, K; Elahi, F; Zielinski, C; Hoecker, P; Steger, G; Schulenburg, A; Neumeister, G; Rabitsch, W; Jakesz, R; Kalhs, P Paclitaxel-containing high-dose chemotherapy in high-risk breast cancer patients.
Acta Oncol. 2000; 39(1):47-52 Doi: 10.1080/028418600430969
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Harousseau, JL; Dekker, AW; Stamatoullas-Bastard, A; Fassas, A; Linkesch, W; Gouveia, J; De Bock, R; Rovira, M; Seifert, WF; Joosen, H; Peeters, M; De Beule, K Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia: a randomized, double-blind, double-placebo, multicenter trial comparing itraconazole and amphotericin B.
Antimicrob Agents Chemother. 2000; 44(7):1887-1893 Doi: 10.1128%2FAAC.44.7.1887-1893.2000 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Kühr, T; Eisterer, W; Apfelbeck, U; Linkesch, W; Bechter, O; Zabernigg, A; Geissler, K; Barbieri, G; Duba, C; Gastl, G; Thaler, J Treatment of patients with advanced chronic myelogenous leukemia with interferon-alpha-2b and continuous oral cytarabine ocfosfate (YNK01): a pilot study.
Leuk Res. 2000; 24(7):583-587 Doi: 10.1016%2FS0145-2126%2800%2900036-9
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Linkesch, W Stem-cell transplantation in patients with germ cell tumors
ACTA MED AUST 2000 27: 30-32.
Web of Science FullText

 

** Neumeister, P; Hoefler, G; Beham-Schmid, C; Sill, H; Linkesch, W Complete remission of generalized relapsed extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type of the gastrointestinal tract after high-dose chemotherapy and autologous peripheral stem cell transplantation.
ANN HEMATOL 2000 79: 703-705. Doi: 10.1007%2Fs002770000203 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Neumeister, P; Strunk, D; Apfelbeck, U; Sill, H; Linkesch, W Adoptive transfer of vitiligo after allogeneic bone marrow transplantation for non-Hodgkin's lymphoma.
Lancet. 2000; 355(9212):1334-1335 Doi: 10.1016/S0140-6736(00)02120-6 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Olipitz, W; Beham-Schmid, C; Aigner, R; Raith, J; Linkesch, W; Sill, H Acute myelofibrosis: multifocal bone marrow infiltration detected by scintigraphy and magnetic resonance imaging.
ANN HEMATOL 2000 79: 275-278. Doi: 10.1007%2Fs002770050593 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Kurzbericht/Letter

** Auner, HW; Beham-Schmid, C; Lindner, G; Fickert, P; Linkesch, W; Sill, H Successful nonsurgical treatment of primary mucosa-associated lymphoid tissue lymphoma of colon presenting with multiple polypoid lesions.
Am J Gastroenterol. 2000; 95(9):2387-2389 Doi: 10.1111/j.1572-0241.2000.02343.x (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Zeitschrift)

** Jager, G; Brezinschek, R; Neumeister, P; Linkesch, W Consolidation with Rituximab(Mab-Thera (TM)) after CHOP-induction as first-line treatment of follicular lymphoma. A phase II study.
BLOOD 2000 96: 240B-240B.
Web of Science

 

** Olipitz, W; Hopfinger, G; Hoefler, G; Girschikofsky, M; Bodner, C; Hiden, K; Aguiar, R; Linkesch, W; Sill, H Microsatellite instability but lack of alternations of genes targeted by defective DNA-mismatch repair in therapy-related MDS and leukemia.
BLOOD 2000 96: 104A-104A.
Web of Science

 

** Rosskopf, K; Wagner, T; Helmberg, W; Sipurzynski, S; Gilli, R; Eibl, M; Linkesch, W; Höfler, G; Lanzer, G CD34 positive compared to one-step positive-negative selection of autologous peripheral blood stem cells (PBSC)
TRANSFUSION 2000 40: 110S-110S.
Web of Science

 

1999

Originalarbeit (Zeitschrift)

** Auner, HW; Klintschar, M; Crevenna, R; Beham-Schmid, C; Hoefler, G; Mitterbauer, G; Linkesch, W; Sill, H Two case studies of chronic idiopathic neutropenia preceding acute myeloid leukaemia.
Br J Haematol. 1999; 105(2):431-433 Doi: 10.1046%2Fj.1365-2141.1999.01322.x (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Auner, HW; Olipitz, W; Hoefler, G; Bodner, C; Konrad, D; Crevenna, R; Linkesch, W; Sill, H Mutational analysis of the DNA mismatch repair gene hMLH1 in myeloid leukaemias.
Br J Haematol. 1999; 106(3):706-708 Doi: 10.1046%2Fj.1365-2141.1999.01595.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Kurzbericht/Letter

** Neumeister, P; Zinke, W; Sill, H; Linkesch, W Antithymocyte globulin may reduce chronic graft versus host disease in patients undergoing unrelated peripheral stem cell transplantation
ONKOLOGIE. 1999; 22(6): 519-519. Doi: 10.1159/000027031 [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

Abstract (Zeitschrift)

** Gilli, R; Sipurzynski, S; Helmberg, W; Wagner, T; Schmidt, H; Neumeister, P; Linkesch, W; Lanzer, G Amount of CD34+ cells in the peripheral blood - a real prediction for the yield of the stem cell concentrate?
BONE MARROW TRANSPLANT 1999 23: S214-S214.
Web of Science

 

** Grube, R; Chraust, S; Linkesch, W; Strunk, D Peripheral blood dendritic cell deficiency in chronic lymphocytic leukemia (CLL) patients.
BLOOD 1999 94: 121A-121A.
Web of Science

 

** Mitterbauer, M; Brugger, S; Neumeister, P; Kalhs, P; Rabitsch, W; Loidolt, H; Keil, F; Hinterberger, W; Linkesch, W; Mannhalter, C; Mitterbauer, G; Greinix, H Clinical and molecular disease eradication after allogeneic stem cell transplantation in patients with advanced non-Hodgkin's lymphoma.
BLOOD 1999 94: 4949-4949.
Web of Science

 

** Neumeister, P; Zinke, W; Schmidt, HH; Linkesch, W Antithymocyte globulin may reduce transplant related mortality and chronic GVHD in patients undergoing allogeneic stem cell transplantation.
BONE MARROW TRANSPLANT 1999 23: S95-S95.
Web of Science

 

** Neumeister, P; Zinke, W; Schmidt, HH; Wagner, T; Linkesch, W Life threatening bradycardia after infusion of cryopreserved stem cells.
BONE MARROW TRANSPLANT 1999 23: S177-S177.
Web of Science

 

** Schloegl, D; Chraust, S; Linkesch, W; Strunk, D Human monocytes do not differentiate into Langerhans cells.
BLOOD 1999 94: 267B-267B.
Web of Science

 

** Zinke, W; Neumeister, P; Linkesch, W Defibrotide - An approach in the treatment of severe hepatic veno-occlusive disease?
BONE MARROW TRANSPLANT 1999 23: S225-S225.
Web of Science

 

1998

Originalarbeit (Zeitschrift)

** Fridrik, MA; Jäger, G; Kienzer, HR; Hausmaninger, H; Oppitz, P; Krieger, O; Zabernigg, A; Lang, A; Neubauer, M; Weidinger, G; Schiller, L; Seewann, HL; Chott, A; Linkesch, W Efficacy and toxicity of 2-Chlorodeoxyadenosine (Cladribine)--2 h infusion for 5 days--as first-line treatment for advanced low grade non-Hodgkin's lymphoma.
Eur J Cancer. 1998; 34(10):1560-1564 Doi: 10.1016%2FS0959-8049%2898%2900140-3
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Hilbe, W; Apfelbeck, U; Fridrik, M; Bernhart, M; Niessner, H; Abbrederis, K; Michlmayr, G; Pont, J; Linkesch, W; Hausmaninger, H; Arneitz, K; Baldinger, C; Duba, C; Eisterer, W; Greil, R; Konwalinka, G; Niederwieser, D; Gastl, G; Thaler, J Interferon-alpha for the treatment of elderly patients with chronic myeloid leukaemia.
LEUK RES. 1998; 22(10): 881-886. Doi: 10.1016/S0145-2126(98)00064-2
Web of Science PubMed FullText FullText_MUG

 

** Reiter, E; Greinix, HT; Brugger, S; Keil, F; Rabitsch, W; Mannhalter, C; Schwarzinger, I; Höcker, P; Fischer, G; Dieckmann, K; Hinterberger, W; Linkesch, W; Schneider, B; Lechner, K; Kalhs, P Long term follow up after allogeneic stem cell transplantation for chronic myelogenous leukemia.
Bone Marrow Transplant. 1998; 22 Suppl 4(8):S86-S88
Web of Science PubMed Google Scholar

 

** Schmidt, HH; Pirc-Danoewinata, H; Panzer-Grümayer, ER; Sill, H; Sedlmayr, P; Neumeister, P; Linkesch, W; Haas, OA Translocation (3;5)(p26;q13) in a patient with chronic T-cell lymphoproliferative disorder.
Cancer Genet Cytogenet. 1998; 104(2):82-85 Doi: 10.1016/S0165-4608(97)00453-6 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Kurzbericht/Letter

** Schmidt, HH; Neumeister, P; Kainer, F; Karpf, EF; Linkesch, W; Sill, H Treatment of essential thrombocythemia during pregnancy: antiabortive effect of interferon-alpha?
Ann Hematol. 1998; 77(6):291-292 Doi: 10.1007%2Fs002770050461
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Editorial

** Linkesch, WM; Payne, R; Meden, H; Cortes-Funes, H; Pangalis, GA Focus on epoetin: key findings of mini-sessions.
SEMIN ONCOL. 1998; 25(3): 69-75.
Web of Science PubMed

 

Abstract (Zeitschrift)

** Auner, HW; Klintschar, M; Beham-Schmid, C; Hoefler, G; Crevenna, R; Linkesch, W Chronic idiopathic neutropenia - A preleukemic disorder?
BLOOD 1998 92: 208B-208B.
Web of Science

 

** Beyer, J; Kramar, A; Mandanas, R; Linkesch, W; Greinix, A; Droz, JP; Pico, JL; Diehl, A; Bokemeyer, C; Schmoll, HJ; Nichols, CR; Einhorn, LH; Siegert, W Prognostic factors for high-dose chemotherapy (HDCT) as salvage treatment in germ cell tumors (GCT)
BONE MARROW TRANSPLANT. 1998; 22: S10-S10.
Web of Science

 

** Fridrik, MA; Greil, R; Jager, G; Kienzer, HR; Hausmaninger, H; Ehrengruber, A; Chott, A; Linkesch, W The influence of low dose interleukin-2 (IL-2) on cladribine (2-CDA) induced CD4-lymphopenia in patients with low grade non-Hodgkin's lymphoma.
BLOOD. 1998; 92(10): 412A-412A.
Web of Science

 

** Gilli, R; Helmberg, W; Jager, G; Schmidt, H; Sipurzynski, S; Wagner, T; Linkesch, W; Lanzer, G Production of peripheral blood stem cell autografts for adults suffering from haematological disorders.
BONE MARROW TRANSPLANT 1998 21: S195-S195.
Web of Science

 

** Greinix, HT; Linkesch, W; Reiter, E; Keil, F; Seifert, M; Czerwenka, K; Elahi, F; Schulenburg, A; Hoecker, P; Kubista, E; Kalhs, P; Vienna, AKH A novel high-dose chemotherapy including paclitaxel with CD34-selected peripheral blood stem cell (PBSC) rescue in high-risk breast cancer patients.
BONE MARROW TRANSPLANT. 1998; 21: S61-S61.
Web of Science

 

** Harousseau, JL; Dekker, A; Stamatoullas, A; Bassaris, H; Linkesch, W; Fassas, A; Fernandez, J; De Bock, B; Cobo, F; Vazquez, L; Seifert, W; De Beule, K Prophylaxis of fungal infections in hematological malignancies: A double blind trial comparing itraconazole oral solution to amphotericin B capsules.
BLOOD. 1998; 92(10): 53B-53B.
Web of Science

 

** Jager, G; Neumeister, P; Hinterleitner, T; Hofler, G; Brezinschek, R; Linkesch, W Cladribine (2-CDA) as a therapy for low-grade MALT-lymphoma: An organ-preserving therapeutic concept.
BLOOD 1998 92: 236B-237B.
Web of Science

 

** Schmidt, HH; Sill, H; Jager, G; Neumeister, P; Strunk, D; Linkesch, W Capillary leak syndrome with late onset after autografting for multiple myeloma.
BONE MARROW TRANSPLANT 1998 21: S91-S91.
Web of Science

 

1997

Originalarbeit (Zeitschrift)

** Breier, F; Oesterreicher, C; Brugger, S; Linkesch, W; Anegg, B; Jurecka, W Immunohistochemistry with monoclonal antibody against Candida albicans mannan antigen demonstrates cutaneous Candida granulomas as evidence of Candida sepsis in an immunosuppressed host.
DERMATOLOGY. 1997; 194(3): 293-296. Doi: 10.1159/000246130 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

** Geissler, K; Koller, E; Hubmann, E; Niederwieser, D; Hinterberger, W; Geissler, D; Kyrle, P; Knöbl, P; Pabinger, I; Thalhammer, R; Schwarzinger, I; Mannhalter, C; Jaeger, U; Heinz, R; Linkesch, W; Lechner, K Granulocyte colony-stimulating factor as an adjunct to induction chemotherapy for adult acute lymphoblastic leukemia--a randomized phase-III study.
BLOOD. 1997; 90(2): 590-596. Doi: 10.1182/blood.V90.2.590.590_590_596 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Neumeister, P; Hoefler, G; Beham-Schmid, C; Schmidt, H; Apfelbeck, U; Schaider, H; Linkesch, W; Sill, H Deletion analysis of the p16 tumor suppressor gene in gastrointestinal mucosa-associated lymphoid tissue lymphomas.
Gastroenterology. 1997; 112(6):1871-1875 Doi: 10.1053%2Fgast.1997.v112.pm9178679
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Thaler, J; Hilbe, W; Apfelbeck, U; Linkesch, W; Sill, H; Seewann, H; Pont, J; Bernhart, M; Stöger, M; Niessner, H; Abbrederis, K; Geissler, D; Hausmaninger, H; Lin, W; Ludwig, H; Lang, A; Duba, C; Fluckinger, T; Greil, R; Grünewald, K; Konwalinka, G; Niederwieser, D; Fridrik, M Interferon-alpha-2C and LD ara-C for the treatment of patients with CML: results of the Austrian multi-center phase II study.
Leuk Res. 1997; 21(1):75-80 Doi: 10.1016%2FS0145-2126%2896%2900084-7
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Virgolini, I; Kurtaran, A; Leimer, M; Smith-Jones, P; Agis, H; Angelberger, P; Kletter, K; Valent, P; Linkesch, W; Eichler, HG Inhalation scintigraphy with iodine-123-labeled interferon gamma-1b: pulmonary deposition and dose escalation study in healthy volunteers.
J Nucl Med. 1997; 38(9): 1475-1481. [OPEN ACCESS]
Web of Science PubMed Google Scholar

 

Kurzbericht/Letter

** Smithjones, PM; Linkesch, W; Virgolini, I Interferon-Gamma for Respiratory-Diseases
LANCET 1997 350: 524-524. Doi: 10.1016/S0140-6736(05)63124-8
Web of Science FullText FullText_MUG

 

Abstract (Zeitschrift)

** Link, H; Wandt, H; SchonrockNabulsi, P; Ehninger, G; Franke, A; Gackle, R; Geer, T; Strobel, G; Linkesch, W; Krieger, O; Niederwieser, D; Nikiforakis, E; Ohl, S; Otremba, B; Pittermann, E; Schmidt, H; Tischler, J; Weiss, J; Wilhelm, M; Badri, N G-CSF (lenograstim) after chemotherapy for acute myeloid leukemia: A placebo controlled randomized trial.
EXP HEMATOL. 1997; 25(8): 35-35.
Web of Science

 

** Strunk, D; Linkesch, W Acute myelogenous leukemia cells can be differentiated into dendritic cells in vitro.
BLOOD 1997 90: 829-829.
Web of Science

 

1996

Originalarbeit (Zeitschrift)

** Beyer, J; Kramar, A; Mandanas, R; Linkesch, W; Greinix, A; Droz, JP; Pico, JL; Diehl, A; Bokemeyer, C; Schmoll, HJ; Nichols, CR; Einhorn, LH; Siegert, W High-dose chemotherapy as salvage treatment in germ cell tumors: a multivariate analysis of prognostic variables.
J Clin Oncol. 1996; 14(10):2638-2645 Doi: 10.1200/JCO.1996.14.10.2638 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Fridrik, MA; Hausmaninger, H; Linkesch, W; Stöger, M; Sill, H; Neubauer, M; Seewann, HL; Klocker, J; Haidinger, R; Schiller, L; Pont, J; Raudaschl, G; Falk, M; Radaszkiewicz, T CEOP-IMVP-Dexa in the treatment of aggressive lymphomas: an Austrian multicenter trial.
J CLIN ONCOL. 1996; 14(1): 227-232. Doi: 10.1200/JCO.1996.14.1.227 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Greinix, HT; Keil, F; Brugger, SA; Reiter, E; Linkesch, W; Lechner, K; Schneider, B; Dieckmann, KU; Fischer, G; Schwarzinger, I; Haas, O; Hinterberger, W; Mannhalter, C; Geissler, K; Hocker, P; Jager, U; Kalhs, P Long-term leukemia-free survival after allogeneic marrow transplantation in patients with acute myelogenous leukemia.
Ann Hematol. 1996; 72(2):53-59 Doi: 10.1007/BF00641308
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Keil, F; Kalhs, P; Haas, OA; Fritsch, G; Mitterbauer, G; Brugger, S; Lechner, K; Schwarzinger, I; Mannhalter, C; Linkesch, W; Kurz, M; Greinix, HT Graft failure after donor leucocyte infusion in relapsed chronic myeloid leukaemia: successful treatment with cyclophosphamide and antithymocyte globulin followed by peripheral blood stem cell infusion.
Br J Haematol. 1996; 94(1):120-122 Doi: 10.1046/j.1365-2141.1996.d01-1770.x (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Kurzbericht/Letter

** Neumeister, P; Linkesch, W; Höfler, G; Sill, H 2-Chlorodeoxyadenosine as first-line treatment in bronchus-associated lymphoid tissue lymphoma.
Blood. 1996; 87(8):3526-3526 Doi: 10.1182/blood.V87.8.3526a.bloodjournal8783526a (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Schmidt, HH; Höfler, G; Beham-Schmid, C; Sill, H; Linkesch, W Bone marrow granulomas in hairy cell leukaemia.
Histopathology. 1996; 29(3):291-292 Doi: 10.1111/j.1365-2559.1996.tb01409.x
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Geissler, K; Koller, E; Hubmann, E; Niederwieser, D; Hinterberger, W; Geissler, D; Kyrle, P; Knobl, P; Pabinger, I; Scherrer, R; Schwarzinger, I; Jaeger, U; Heinz, R; Linkesch, W; Lechner, K Concomitant administration of granulocyte colony-stimulating factor (G-CSF) and induction chemotherapy of adult acute lymphoblastic leukemia (ALL) - A multicenter openlabel, phase III study in randomized parallel groups
BRIT J HAEMATOL 1996 93: 221-221.
Web of Science

 

** Link, H; Wandt, H; SchonrockNabulsi, P; Ehninger, G; Franke, A; Gackle, R; Geer, T; Gramatzki, M; Linkesch, W; Lutz, D; Niederwieser, D; Nikiforakis, E; Ohl, S; Otremba, B; Pittermann, E; Schmidt, H; Tischler, J; Weiss, J; Wilhelm, M; Deutschmann, S G-CSF after chemotherapy for acute myeloid leukemia (AML) - Interim analysis of a placebo controlled trial
BRIT J HAEMATOL. 1996; 93: 841-841.
Web of Science

 

** Link, H; Wandt, H; SchonrockNabulsi, P; Ehninger, G; Franke, A; Gackle, R; Geer, T; Strobel, G; Linkesch, W; Krieger, O; Niederwieser, D; Nikiforakis, E; Ohl, S; Otremba, B; Pittermann, E; Schmidt, H; Tischler, J; Weiss, J; Wilhelm, M; Badri, N G-CSF (lenograstim) after chemotherapy for acute myeloid leukemia: A placebo controlled trial.
BLOOD. 1996; 88(10): 2654-2654.
Web of Science

 

** Neumeister, P; Hofler, G; BehamSchmid, C; Schmidt, H; Apfelbeck, U; Linkesch, W; Sill, H Homozygous deletions of the p16 gene in high-grade gastric malt lymphomas.
BLOOD 1996 88: 3311-3311.
Web of Science

 

1995

Originalarbeit (Zeitschrift)

** FRIDRIK, MA; FELBERMAYR, M; LINKESCH, W; NEUBAUER, M; SCHILLER, L; HAUSMANINGER, H; OPPITZ, P; GATTRINGER, C 2-CHLORODESOXYADENOSINE - FIRST-LINE TREATMENT FOR LOW-GRADE NON-HODGKINS-LYMPHOMAS - A PHASE-II/III STUDY OF THE ARBEITSGEMEINSCHAFT-MEDIKAMENTOSE-TUMORTHERAPIE
ONKOLOGIE. 1995; 18(1): 39-43. Doi: 10.1159/000218552
Web of Science FullText FullText_MUG

 

** Kalhs, P; Brugger, S; Schwarzinger, I; Greinix, HT; Keil, F; Kyrle, PA; Knöbl, P; Schneider, B; Höcker, P; Linkesch, W Microangiopathy following allogeneic marrow transplantation. Association with cyclosporine and methylprednisolone for graft-versus-host disease prophylaxis.
Transplantation. 1995; 60(9):949-957 Doi: 10.1097/00007890-199511150-00012
Web of Science PubMed FullText FullText_MUG

 

** Mitterbauer, G; Födinger, M; Scherrer, R; Knöbl, P; Jäger, U; Laczika, K; Schwarzinger, I; Gaiger, A; Geissler, K; Greinix, H PCR-monitoring of minimal residual leukaemia after conventional chemotherapy and bone marrow transplantation in BCR-ABL-positive acute lymphoblastic leukaemia.
Br J Haematol. 1995; 89(4):937-941 Doi: 10.1111/j.1365-2141.1995.tb08444.x
Web of Science PubMed FullText FullText_MUG

 

** Wiltschke, C; Krainer, M; Nanut, M; Wagner, A; Linkesch, W; Zielinski, CC In vivo administration of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor increases neutrophil oxidative burst activity.
J INTERFERON CYTOKINE RES. 1995; 15(3): 249-253. Doi: 10.1089/jir.1995.15.249
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Wiltschke, C; Krainer, M; Wagner, A; Linkesch, W; Zielinski, CC Influence of in vivo administration of GM-CSF and G-CSF on monocyte cytotoxicity.
EXP HEMATOL. 1995; 23(5): 402-406.
Web of Science PubMed Google Scholar

 

Kurzbericht/Letter

** Wagner, A; Mayer, G; Röggla, G; Linkesch, W Successful treatment of acute renal failure related to bone-marrow transplantation.
NEPHROL DIALYSIS TRANSPLANT. 1995; 10(7): 1255-1256. Doi: 10.1093/ndt/10.7.1255 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Übersichtsarbeit

** Höcker, P; Knapp, W; Linkesch, W; Geissler, K; Peters, C; Hinterberger, W; Wagner, A Collection and long-term preservation of peripheral stem cells
Wien Med Wochenschr. 1995; 145(2-3):27-29
PubMed

 

** Schmidt, HH; Sill, H; Eibl, M; Beham-Schmid, C; Höfler, G; Haas, OA; Krejs, GJ; Linkesch, W Hodgkin's disease developing after spontaneous remission of chronic lymphocytic leukemia.
Ann Hematol. 1995; 71(5):247-252 Doi: 10.1007/s002770050113 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Zeitschrift)

** Fridrik, MA; Linkesch, W; Jager, G; Kienzer, HJ; Hausmaninger, H; Krieger, O; Neubauer, M; Gattringer, C; Oppitz, P; Schiller, L Response and toxicity of cladribine (2-CdA) as first line treatment of low-grade non-Hodgkin's lymphomas (NHL). Preliminary data of an Austrian multicenter trial
BLOOD. 1995; 86(10): 210-210.
Web of Science

 

** Kalhs, P; Brugger, S; Keil, F; Hocker, P; Hawliczek, R; Hinterberger, W; Lechner, K; Linkesch, W; Greinix, HT Allogeneic marrow transplantation beyond the age of 40 years in patients with hematological malignancy.
BLOOD. 1995; 86(10): 3791-3791.
Web of Science

 

** Keil, F; Kalhs, F; Haas, O; Fritsch, G; Brugger, S; Schwarzinger, ERI; Mannhalter, C; Linkesch, W; Hocker, P; Lechner, K; Greinix, HT Prolonged aplasia after donor leukocyte infusion in relapsed CML unresponsive to bone marrow infusion: Successful treatment with cyclophosphamide and antithymocyte globulin followed by PBSC.
BLOOD. 1995; 86(10): 3794-3794.
Web of Science

 

1994

Originalarbeit (Zeitschrift)

** Greinix, HT; Linkesch, W; Keil, F; Kalhs, P; Schwarzinger, I; Schneider, B; Oesterreicher, C; Brugger, S; Kapiotis, S; Lechner, K Early detection of hematopoietic engraftment after bone marrow and peripheral blood stem cell transplantation by highly fluorescent reticulocyte counts.
Bone Marrow Transplant. 1994; 14(2):307-313
Web of Science PubMed Google Scholar

 

** Kusec, R; Laczika, K; Knöbl, P; Friedl, J; Greinix, H; Kahls, P; Linkesch, W; Schwarzinger, I; Mitterbauer, G; Purtscher, B AML1/ETO fusion mRNA can be detected in remission blood samples of all patients with t(8;21) acute myeloid leukemia after chemotherapy or autologous bone marrow transplantation.
Leukemia. 1994; 8(5):735-739
Web of Science PubMed Google Scholar

 

** Link, H; Boogaerts, MA; Fauser, AA; Slavin, S; Reiffers, J; Gorin, NC; Carella, AM; Mandelli, F; Burdach, S; Ferrant, A; Linkesch, W; Tura S; Bacigalupo A, Schindel, F; Heinrichs, H A controlled trial of recombinant human erythropoietin after bone marrow transplantation.
BLOOD. 1994; 84(10): 3327-3335. Doi: 10.1182/blood.V84.10.3327.bloodjournal84103327 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** GREINIX, HT; KEIL, F; KNAPP, S; BRUGGER, S; KALHS, P; LINKESCH, W; LECHNER, K; JAEGER, U ALLOGENEIC MARROW TRANSPLANTATION FOR ADVANCED-STAGE T(14-18) NON-HODGKINS-LYMPHOMA ELIMINATES PCR DETECTABLE CELLS FROM PERIPHERAL-BLOOD AND BONE-MARROW
BLOOD. 1994; 84(10): A214-A214.
Web of Science

 

** KALHS, P; BRUGGER, S; SCHWARZINGER, I; GREINIX, HT; KEIL, F; KYRLE, PA; KNOBL, P; LINKESCH, W; LECHNER, K SEVERE MICROANGIOPATHY IN PATIENTS RECEIVING CYCLOSPORINE-A AND METHYLPREDNISOLONE (CSA-MP) FOR GVHD PROPHYLAXIS AFTER ALLOGENEIC MARROW TRANSPLANTATION
BLOOD. 1994; 84(10): A489-A489.
Web of Science

 

Kurzbericht/Note

** Thalhammer, F; Gisslinger, H; Chott, A; Haas, O; Etele-Hainz, A; Helbich, T; Kusec, R; Linkesch, W; Simonitsch, I; Strobl, H Granulocytic sarcoma of the prostate as the first manifestation of a late relapse of acute myelogenous leukemia.
Ann Hematol. 1994; 68(2):97-99 Doi: 10.1007/BF01715141 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1993

Originalarbeit (Zeitschrift)

** Gaiger, A; Lion, T; Kalhs, P; Mitterbauer, G; Henn, T; Haas, O; Födinger, M; Kier, P; Forstinger, C; Quehenberger, P; Hinterberger, W; Jager, U; Linkesch, W; Mannhalter, C; Lechner, K Frequent detection of BCR-ABL specific mRNA in patients with chronic myeloid leukemia (CML) following allogeneic and syngeneic bone marrow transplantation (BMT).
LEUKEMIA. 1993; 7(11): 1766-1772.
Web of Science PubMed Google Scholar

 

** Höcker, P; Knapp, W; Linkesch, W; Geissler, K; Peters, C; Hinterberger, W; Wagner, A Collection and long-term preservation of peripheral stem cells
Beitr Infusionsther. 1993; 31: 130-135.
PubMed Google Scholar

 

** PHILIP, T; LADENSTEIN, R; LINKESCH, W RECENT ASPECTS ON THE ROLE OF MEGATHERAPY FOLLOWED BY BONE-MARROW RESCUE IN HIGH-RISK NEUROBLASTOMA, MALIGNANT BRAIN GLIOMAS AND POOR-PROGNOSIS EWING SARCOMA
BONE MARROW TRANSPLANT. 1993; 12: S82-S84.
Web of Science

 

** Röggla, G; Linkesch, M; Röggla, M; Wagner, A; Haber, P; Linkesch, W A rare complication of a central venous catheter system (Port-a-Cath). A case report of a catheter embolization after catheter fracture during power training.
Int J Sports Med. 1993; 14(6):345-346 Doi: 10.1055/s-2007-1021190 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Zeitschrift)

** LINK, H; FAUSER, A; HUBNER, G; BACIGALUPO, A; BOOGAERTS, M; BURDACH, S; CARELLA, A; FERRANT, A; GOLDSTONE, A; GORIN, N; KRIEGER, O; LINKESCH, W; MANDELLI, F; MCCANN, S; REIFFERS, J; SLAVIN, S; STEWARD, W; TURA, S; ZINTL, F; SCHINDELKUNZEL, F; HEINRICHS, H CLINICAL BONE-MARROW TRANSPLANTATION .3. RECOMBINANT-HUMAN-ERYTHROPOIETIN AFTER BONE-MARROW TRANSPLANTATION - A PROSPECTIVE PLACEBO-CONTROLLED TRIAL IN EUROPE
BLOOD. 1993; 82(10): A284-A284.
Web of Science

 

1992

Originalarbeit (Zeitschrift)

** Gisslinger, H; Gilly, B; Woloszczuk, W; Mayr, WR; Havelec, L; Linkesch, W; Weissel, M Thyroid autoimmunity and hypothyroidism during long-term treatment with recombinant interferon-alpha.
Clin Exp Immunol. 1992; 90(3):363-367 Doi: 10.1111/j.1365-2249.1992.tb05852.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Link, H; Boogaerts, MA; Carella, AM; Ferrant, A; Gadner, H; Gorin, NC; Harabacz, I; Harousseau, JL; Hervé, P; Holldack, J; Linkesch, W; et al. A controlled trial of recombinant human granulocyte-macrophage colony-stimulating factor after total body irradiation, high-dose chemotherapy, and autologous bone marrow transplantation for acute lymphoblastic leukemia or malignant lymphoma.
BLOOD. 1992; 80(9): 2188-2195. Doi: 10.1182/blood.V80.9.2188.2188 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** LINKESCH, W; KRAINER, M; WAGNER, A PHASE-I/II TRIAL OF ULTRAHIGH CARBOPLATIN, ETOPOSIDE CYCLOPHOSPHAMIDE WITH ABMT IN REFRACTORY OR RELAPSED NONSEMINOMATOUS GERM-CELL TUMORS
BONE MARROW TRANSPLANT. 1992; 10: 28-29.
Web of Science Google Scholar

 

** Reichel, RP; Linkesch, W; Schetitska, D Therapy with recombinant interferon alpha-2c during unexpected pregnancy in a patient with chronic myeloid leukaemia.
Br J Haematol. 1992; 82(2):472-473 Doi: 10.1111/j.1365-2141.1992.tb06447.x (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Kurzbericht/Letter

** Pirker, R; Wallner, J; Götzl, M; Gsur, A; Geissler, K; Havelec, L; Knapp, W; Haas, O; Linkesch, W; Lechner, K MDR1 RNA expression is an independent prognostic factor in acute myeloid leukemia.
Blood. 1992; 80(2):557-559 Doi: 10.1182/blood.V80.2.557.bloodjournal802557 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1991

Originalarbeit (Zeitschrift)

** Gisslinger, H; Chott, A; Scheithauer, W; Gilly, B; Linkesch, W; Ludwig, H Interferon in essential thrombocythaemia.
Br J Haematol. 1991; 79 Suppl 1(1):42-47 Doi: 10.1111/j.1365-2141.1991.tb08118.x
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Pirker, R; Wallner, J; Geissler, K; Linkesch, W; Haas, OA; Bettelheim, P; Hopfner, M; Scherrer, R; Valent, P; Havelec, L MDR1 gene expression and treatment outcome in acute myeloid leukemia.
J Natl Cancer Inst. 1991; 83(10):708-712 Doi: 10.1093/jnci/83.10.708 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Stefenelli, T; Linkesch, W; Radaszkiewicz, T Myelosarcoma of the ovary
WIEN KLIN WOCHENSCHR. 1991; 103(23): 717-718. (- Case Report)
Web of Science PubMed

 

Kurzbericht/Note

** Scheithauer, W; Dittrich, C; Kornek, G; Haider, K; Linkesch, W; Gisslinger, H; Depisch, D Phase II study of amonafide in advanced breast cancer.
Breast Cancer Res Treat. 1991; 20(1):63-67 Doi: 10.1007/BF01833358
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1990

Originalarbeit (Zeitschrift)

** Chott, A; Gisslinger, H; Thiele, J; Fritz, E; Linkesch, W; Radaszkiewicz, T; Ludwig, H Interferon-alpha-induced morphological changes of megakaryocytes: a histomorphometrical study on bone marrow biopsies in chronic myeloproliferative disorders with excessive thrombocytosis.
BRIT J HAEMATOL. 1990; 74(1): 10-16. Doi: 10.1111/j.1365-2141.1990.tb02531.x
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Gisslinger, H; Chott, A; Linkesch, W; Fritz, E; Ludwig, H Long-term alpha-interferon therapy in myelodysplastic syndromes.
Leukemia. 1990; 4(2):91-94
Web of Science PubMed Google Scholar

 

** Knobler, RM; Pirker, R; Kokoschka, EM; Ludwig, H; Linkesch, W; Micksche, M Experimental treatment of chronic lymphocytic leukemia with extracorporeal photochemotherapy. Initial observations.
Blut. 1990; 60(4):215-218 Doi: 10.1007/BF01728786 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Linkesch, W; Thaler, J; Gattringer, C; Konwalinka, G Continuous infusion of mitoxantrone combined with high-dose cytarabine in refractory/relapsed acute myeloblastic leukemia and blast crisis of chronic myelogenous leukemia.
Haematol Blood Transfus. 1990; 33:330-332 Doi: 10.1007/978-3-642-74643-7_62
PubMed FullText FullText_MUG Google Scholar

 

** Scheithauer, W; Gisslinger, H; Temsch, EM; Linkesch, M; Linkesch, W; Ludwig, H Effect of recombinant interferon-alpha2C on reticuloendothelial function in patients with thrombocytosis.
J INTERFERON RES. 1990; 10(2): 237-242. Doi: 10.1089/jir.1990.10.237
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Sinzinger, H; Gisslinger, H; Linkesch, W; Peskar, BA Defects in the prostaglandin system. IX. Lipoxygenase defect of thrombocytes in a patient with polycythemia vera
WIEN KLIN WOCHENSCHR. 1990; 102(3): 74-76. (- Case Report)
Web of Science PubMed Google Scholar

 

** Sinzinger, H; Linkesch, W; Ludwig, H; Gisslinger, H; O'Grady, J; Peskar, BA Impaired conversion of exogenous arachidonic acid by platelets to thromboxane B2 and correction of that deficiency by interferon-alpha.
Prostaglandins. 1990; 40(4):351-360 Doi: 10.1016/0090-6980(90)90100-A
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Zeitschrift)

** KRAUPP, M; LEGENSTEIN, E; LINKESCH, W; WATZINGER, U; GRAF, H INFLUENCE OF RECOMBINANT ERYTHROPOIETIN ON HEME-BIOSYNTHESIS IN CHRONIC UREMIC PATIENTS
CLIN CHEM. 1990; 36(6): 974-974.
Web of Science

 

1989

Originalarbeit (Zeitschrift)

** Chiba, P; Tihan, T; Eher, R; Köller, U; Wallner, C; Göbl, R; Linkesch, W Effect of cell growth and cell differentiation on 1-beta-D-arabinofuranosylcytosine metabolism in myeloid cells.
Br J Haematol. 1989; 71(4):451-455 Doi: 10.1111/j.1365-2141.1989.tb06301.x
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Flores, J; Richter, H; Weiss, K; Linkesch, W; Widhalm, K; Kuzmits, R; Sinzinger, H Cholesterol screening in a bank for the detection of a risk population
WIEN KLIN WOCHENSCHR. 1989; 101(12): 419-423.
Web of Science PubMed

 

** Flores, J; Widhalm, K; Kuzmits, R; Linkesch, W; Sabeti, M; Sinzinger, H The cholesterol risk factor--initial results of a screening study in industries
WIEN KLIN WOCHENSCHR. 1989; 101(12): 412-417.
Web of Science PubMed

 

** Gisslinger, H; Ludwig, H; Linkesch, W; Chott, A; Fritz, E; Radaszkiewicz, T Long-term interferon therapy for thrombocytosis in myeloproliferative diseases.
Lancet. 1989; 1(8639):634-637 Doi: 10.1016/S0140-6736(89)92142-9
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Linkesch, W; Michlmayr, G; Gerhartz, H; Illinger, H; König, H; Düllmann, J; Keilhauer, R; Moldrzyk, D Amsacrine, cytarabine and thioguanine (AAT) versus daunorubicin, cytarabine, thioguanine (DAT) in adults with untreated acute non-lymphoblastic leukemia (ANLL). Austrian-German results.
Onkologie. 1989; 12(1):8-10 Doi: 10.1159/000216587
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Müller, C; Zielinski, CC; Linkesch, W; Ludwig, H; Sinzinger, H In vivo tracing of indium-111 oxine-labeled human peripheral blood mononuclear cells in patients with lymphatic malignancies.
J Nucl Med. 1989; 30(6):1005-1011 [OPEN ACCESS]
Web of Science PubMed Google Scholar

 

** Pirker, R; Goldstein, LJ; Ludwig, H; Linkesch, W; Lechner, C; Gottesman, MM; Pastan, I Expression of a multidrug resistance gene in blast crisis of chronic myelogenous leukemia.
Cancer Commun. 1989; 1(2):141-144 Doi: 10.3727/095535489820875354 (- Case Report)
PubMed FullText FullText_MUG Google Scholar

 

** Watzke, HH; Linkesch, W; Hay, U Giant hemangioma of the liver (Kasabach-Merritt syndrome): successful suppression of intravascular coagulation permitting surgical removal.
J Clin Gastroenterol. 1989; 11(3):347-350 Doi: 10.1097/00004836-198906000-00022 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1988

Originalarbeit (Zeitschrift)

** Gruber, K; Linkesch, W; Mayr, B Filamentous appearance of DA-DAPI positive heterochromatin in leukemic cells.
HAEMATOLOGICA. 1988; 73(2): 105-109. [OPEN ACCESS]
Web of Science PubMed

 

** Ludwig, H; Scheithauer, W; Kührer, I; Kuzmits, R; Gisslinger, G; Linkesch, W; Zielinski, C; Fritz, E Interferon therapy in multiple myeloma
ONKOLOGIE. 1988; 11(4): 192-196. Doi: 10.1159/000216520
Web of Science PubMed FullText FullText_MUG

 

** Ollenschläger, G; Roth, E; Linkesch, W; Jansen, S; Simmel, A; Mödder, B Asparaginase-induced derangements of glutamine metabolism: the pathogenetic basis for some drug-related side-effects.
Eur J Clin Invest. 1988; 18(5):512-516 Doi: 10.1111/j.1365-2362.1988.tb01049.x
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Preis, PP; Zielinski, CC; Linkesch, W; Bettelheim, P; Radaskiewicz, T; Pavelka, M; Haas, O; Aiginger, P Shift in phenotype of acute T-lymphocytic leukemia to eosinophilic leukemia: a case report.
Wien Klin Wochenschr. 1988; 100(10):331-336 (- Case Report)
Web of Science PubMed Google Scholar

 

** Sinzinger, H; Gisslinger, H; Linkesch, W; Ludwig, H; Flener, R; Peskar, BA Defects in the prostaglandin system. VIII. A pathologic thrombocyte population in myeloproliferative syndrome, which forms no thromboxane from exogenous arachidonic acid
Wien Klin Wochenschr. 1988; 100(21):715-718 (- Case Report)
Web of Science PubMed Google Scholar

 

Abstract (Zeitschrift)

** CHIBA, P; TIHAN, T; EHER, R; POLTL, E; LINKESCH, W EFFECT OF CELL-GROWTH AND DIFFERENTIATION ON 1-BETA-D-ARABINOFURANOSYLCYTOSINE METABOLISM IN MYELOID CELLS
BLUT. 1988; 57(4): 202-202.
Web of Science

 

** CHOTT, A; THIELE, J; GISSLINGER, H; LINKESCH, W; FRITZ, E; RADASZKIEWICZ, T; LUDWIG, H MORPHOLOGICAL-CHANGES OF MEGAKARYOCYTES DURING INTERFERON TREATMENT OF CHRONIC MYELOPROLIFERATIVE DISORDERS WITH EXCESSIVE THROMBOCYTOSIS (CMPDWET)
BLUT. 1988; 57(4): 231-231.
Web of Science

 

** GISSLINGER, H; WEISSEL, M; KUHRER, I; LINKESCH, W; LUDWIG, H OCCURRENCE OF THYROID AUTOIMMUNITY IN PATIENTS ON LONG-TERM THERAPY WITH RECOMBINANT INTERFERON-ALPHA
BLUT. 1988; 57(4): 225-225.
Web of Science

 

** GRANINGER, W; MORAWETZ, A; LINKESCH, W; SMOLEN, J MOLECULAR MONITORING OF PATIENTS WITH CHRONIC MYELOID-LEUKEMIA DURING INTERFERON TREATMENT
BLUT. 1988; 57(4): 194-194.
Web of Science

 

** HAWLICZEK, R; EMMINGER, W; EMMINGERSCHMIDMEIER, W; LINKESCH, W; GADNER, H; HINTERBERGER, W; HOCKER, P; HAVELEZ, L MUCOSAL TOXICITY IS POSSIBLY RELATED TO EARLY MORTALITY FOLLOWING SUPRALETHAL CHEMO-RADIOTHERAPY AND STEM-CELL GRAFTING
BLUT. 1988; 57(4): 199-199.
Web of Science

 

** HOCKER, P; HINTERBERGER, W; EMMINGERSCHMIDMEIER, W; LINKESCH, W; RITSCHL, P; GERHARTL, K; WAGNER, A COLLECTION, STORAGE AND RETRANSFUSION OF PERIPHERAL-BLOOD STEM-CELLS (PBSC)
BLUT. 1988; 57(4): 267-267.
Web of Science

 

** MICKSCHE, M; GISSLINGER, H; SCHEITHAUER, W; LINKESCH, W; LUDWIG, H NATURAL-KILLER CELL-ACTIVITY IN PERIPHERAL-BLOOD AND BONE-MARROW OF PATIENTS WITH MYELOMA, MYELODYSPLASTIC AND MYELOPROLIFERATIVE DISEASES
BLUT. 1988; 57(4): 234-234.
Web of Science

 

1987

Originalarbeit (Zeitschrift)

** Killian, W; Riederer, P; Linkesch, W Serum iron status in Rett syndrome.
BRAIN DEVELOP. 1987; 9(5): 523-524. Doi: 10.1016/S0387-7604(87)80077-3
Web of Science PubMed FullText FullText_MUG

 

** Ludwig, H; Linkesch, W; Gisslinger, H; Fritz, E; Sinzinger, H; Radaszkiewicz, T; Chott, A; Flener, R; Micksche, M Interferon-alfa corrects thrombocytosis in patients with myeloproliferative disorders.
Cancer Immunol Immunother. 1987; 25(3):266-273 Doi: 10.1007/BF00199157
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Übersichtsarbeit

** Linkesch, W Review.The importance of serum ferritin in the clinic and diagnosis
Folia Haematol Int Mag Klin Morphol Blutforsch. 1987; 114(3): 291-318.
PubMed

 

Abstract (Zeitschrift)

** GRUBER, K; LINKESCH, W; KAIN, R NUCLEOLAR PATTERNS IN NORMAL GRANULOPOIESIS AND MYELOBLASTIC-LEUKEMIA
BLUT. 1987; 55(4): 318-318.
Web of Science

 

** GRUBER, K; LINKESCH, W; MAYR, B DA-DAPI-POSITIVE HETEROCHROMATIN AND NUCLEOLI IN LEUKEMIC-CELLS
ONKOLOGIE. 1987; 10(5): 278-278.
Web of Science

 

** HAWLICZEK, R; SCHMIDMEIER, W; LINKESCH, W; HACKL, A; URBAN, C ACUTE TOXICITY OF HYPERFRACTIONATED TOTAL-BODY IRRADIATION IN COMBINATION WITH DIFFERENT CONDITIONING REGIMENS - PRELIMINARY-REPORT
STRAHLENTHER ONKOL. 1987; 163(4): 247-247.
Web of Science

 

** KUHRER, I; LINKESCH, W; LUDWIG, H; GISSLINGER, H RESULTS OF RECOMBINANT ALPHA-2-C-INTERFERON THERAPY IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA (CML)
BLUT. 1987; 55(4): 390-390.
Web of Science

 

** KUHRER, I; LINKESCH, W; LUDWIG, H; GISSLINGER, H INTERFERON THERAPY (REC-IFN-ALPHA-2C) IN CHRONIC MYELOID-LEUKEMIA
ONKOLOGIE. 1987; 10(5): 281-281.
Web of Science

 

** LINKESCH, M; PRAGER, R; KLAUSER, R; LINKESCH, W; GISSLINGER, H; SCHERNTHANER, G EFFECT OF CHRONIC HYPERGLUCAGONEMIA ON GLUCOSE-TOLERANCE, INSULIN RESISTANCE AND INSULIN ACTION
DIABETOLOGIA. 1987; 30(7): A550-A550.
Web of Science

 

** LINKESCH, W; SINZINGER, H; LUDWIG, H; GISSLINGER, H TREATMENT WITH RIFN-ALPHA-2C CAN NORMALIZE ABNORMAL CONVERSION OF 14C-ARACHIDONIC ACID (AA) IN MYELOPROLIFERATIVE SYNDROME (MPS)
BLUT. 1987; 55(4): 387-387.
Web of Science

 

** RASOULROCKENSCHAUB, S; LINKESCH, W; ZIELINSKI, C; LUDWIG, H VINDESINE-PREDNISOLONE THERAPY IN RECURRENT MULTIPLE-MYELOMA NOT RESPONDING TO CHEMOTHERAPY
ONKOLOGIE. 1987; 10(5): 279-279.
Web of Science

 

** SCHEITHAUER, W; GISSLINGER, H; LINKESCH, W; LINKESCH, M; LUDWIG, H EFFECT OF RECOMBINANT INTERFERON ALPHA-2C (RIFN-A2) ON INVIVO FC-DEPENDENT PHAGOCYTIC-ACTIVITY OF THE RETICULOENDOTHELIAL SYSTEM (RES)
BLUT. 1987; 55(4): 254-254.
Web of Science

 

1986

Originalarbeit (Zeitschrift)

** Kollegger, H; Preis, P; Maida, E; Zielinski, CC; Linkesch, W; Bettelheim, P; Aiginger, P CSF cytology of a patient with conversion of an acute lymphatic leukemia to an acute eosinophilic leukemia.
Eur Neurol. 1986; 25(5):320-326 Doi: 10.1159/000116029 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Kuzmits, R; Aiginger, P; Müller, MM; Steurer, G; Linkesch, W Assessment of the sensitivity of leukaemic cells to cytotoxic drugs by bioluminescence measurement of ATP in cultured cells.
CLIN SCI. 1986; 71(1): 81-88. Doi: 10.1042/cs0710081
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Kurzbericht/Letter

** Kührer, I; Kuzmits, R; Linkesch, W; Ludwig, H Topical PGE2 enhances healing of chemotherapy-associated mucosal lesions.
LANCET. 1986; 1(8481): 623-623. Doi: 10.1016/S0140-6736(86)92850-3
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Zeitschrift)

** GISSLINGER, H; LINKESCH, W; CHOTT, A; SINZINGER, H; LUDWIG, H LONG-TERM RESULTS IN THE TREATMENT OF EXCESSIVE THROMBOCYTOSIS IN MYELOPROLIFERATIVE DISORDERS WITH RECOMBINANT ALPHA-2C INTERFERON
BLUT. 1986; 53(3): 128-128.
Web of Science

 

** GISSLINGER, H; LINKESCH, W; HOCKER, P; CHOTT, A; SINZINGER, H; LUDWIG, H TREATMENT OF MYELODYSPLASTIC SYNDROMES WITH RECOMBINANT INTERFERON-ALPHA-2C
ACTA MED AUST. 1986; 13: 67-67.
Web of Science

 

** GISSLINGER, H; LINKESCH, W; HOCKER, P; SINZINGER, H; FLENER, R; LUDWIG, H THE TREATMENT OF MYELODYSPLASTIC SYNDROMES WITH RECOMBINANT INTERFERON-ALPHA-2C
WIEN KLIN WOCHENSCHR. 1986; 98(17): 590-590.
Web of Science

 

** GISSLINGER, H; LINKESCH, W; PANZER, S; CHOTT, A; SCHERNTHANER, G; LUDWIG, H USE OF DANAZOL FOR TREATMENT OF IMMUNE THROMBOCYTOPENIA
ACTA MED AUST. 1986; 13(1): 24-25.
Web of Science

 

** KUHRER, I; LUDWIG, H; LINKESCH, W; CORTELEZZI, A; POLLI, E; KUZMITS, R; FLENER, R COMBINED INTERFERON AND POLYCHEMOTHERAPY VERSUS POLYCHEMOTHERAPY ALONE IN MULTIPLE-MYELOMA
BLUT. 1986; 53(3): 129-129.
Web of Science

 

** KUHRER, I; LUDWIG, H; LINKESCH, W; CORTELEZZI, A; POLLI, E; ROCKENSCHAUB, S; KUZMITS, R; FLENER, R COMPARISON OF THE EFFICIENCY OF COMBINED INTERFERON POLYCHEMOTHERAPY VERSUS POLYCHEMOTHERAPY IN MULTIPLE-MYELOMA
WIEN KLIN WOCHENSCHR. 1986; 98(17): 588-588.
Web of Science

 

** STEFENELLI, T; RADASZKIEWICZ, T; LINKESCH, W THE THERAPY OF MYELOSARCOMAS
WIEN KLIN WOCHENSCHR. 1986; 98(17): 589-589.
Web of Science

 

1985

Originalarbeit (Zeitschrift)

** Bettelheim, P; Lutz, D; Majdic, O; Paietta, E; Haas, O; Linkesch, W; Neumann, E; Lechner, K; Knapp, W Cell lineage heterogeneity in blast crisis of chronic myeloid leukaemia.
BRIT J HAEMATOL. 1985; 59(3): 395-409. Doi: 10.1111/j.1365-2141.1985.tb07326.x
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Kovarik, J; Irschik, H; Graf, H; Woloszczuk, W; Meisinger, V; Linkesch, W; Stummvoll, HK Iron removal by desferrioxamine in patients on chronic hemodialysis--kinetic study and long-term results.
Contrib Nephrol. 1985; 49(3):44-55
PubMed Google Scholar

 

** Linkesch, W; Gisslinger, H; Ludwig, H; Flener, R; Sinzinger, H Therapy with interferon (recombinant IFN-alpha-2C) in myeloproliferative diseases with severe thrombocytoses
Acta Med Austriaca. 1985; 12(5):123-127
Web of Science PubMed Google Scholar

 

** Ludwig, H; Cortelezzi, A; Van Camp, BG; Polli, E; Scheithauer, W; Kuzmits, R; Linkesch, W; Gisslinger, H; Sinzinger, H; Fritz, E Treatment with recombinant interferon-alpha-2C: multiple myeloma and thrombocythaemia in myeloproliferative diseases.
Oncology. 1985; 42 Suppl 1(3):19-25 Doi: 10.1159/000226080
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Zeitschrift)

** BRICHTA, A; PREIS, P; LINKESCH, W; GISSLINGER, H; HOCKER, P LOW PERIPHERAL LEVELS OF CFU-GM IN PATIENTS WITH CML AND EXCESSIVE THROMBOCYTOSIS
BLUT. 1985; 51(3): 179-179.
Web of Science

 

** GISSLINGER, H; PREIS, P; LINKESCH, W HIGH-DOSE CYTOSINE-ARABINOSIDE IN THE TREATMENT OF REFRACTORY ACUTE MYELOGENOUS LEUKEMIA (AML)
BLUT. 1985; 51(3): 210-210.
Web of Science

 

** KOVARIK, J; GRAF, H; WOLOSZCZUK, W; MEISINGER, V; LINKESCH, W; STUMMVOLL, HK; IRSCHIK, H DESFERAL TREATMENT OF HEMOSIDEROSIS SUBJECT TO TRANSFUSION IN PATIENTS WITH CHRONIC-HEMODIALYSIS THERAPY
ACTA MED AUST. 1985; 12(3-4): 72-72.
Web of Science

 

** KUZMITS, R; AIGINGER, P; STEURER, G; LINKESCH, W; MULLER, MM DETERMINATION OF DRUG-INDUCED CYTO-TOXICITY IN ACUTE-LEUKEMIA USING FIREFLY BIOLUMINESCENCE INVITRO
BLUT. 1985; 51(3): 152-153.
Web of Science

 

** KUZMITS, R; STEURER, G; LINKESCH, W; LUDWIG, H EFFECT OF CYTOSTATIC AGENTS ON GRANULOCYTE FUNCTION (PMA-INDUCED PRODUCTION OF SUPEROXIDES)
BLUT. 1985; 51(3): 182-182.
Web of Science

 

** KUZMITS, R; STEURER, G; LINKESCH, W; LUDWIG, H; LEGENSTEIN, E INFLUENCE OF CYTOSTATIC AGENTS ON OXIDATIVE-METABOLISM (RESPIRATORY BURST) OF GRANULOCYTES
ACTA MED AUST. 1985; 12: 43-43.
Web of Science

 

** LINKESCH, W CLINICAL-VALUE OF SERUM FERRITIN IN MALIGNANT DISEASES
ACTA MED AUST. 1985; 12: 48-49.
Web of Science

 

** LINKESCH, W COMPLETELY IMPLANTABLE CATHETER SYSTEM - 1ST CLINICAL-EXPERIENCES
ACTA MED AUST. 1985; 12: 49-49.
Web of Science

 

** LINKESCH, W; FLENER, R; GISSLINGER, H; LUDWIG, H; SINZINGER, H TREATMENT FOR EXCESSIVE THROMBOCYTOSIS IN MYELOPROLIFERATIVE DISORDERS WITH RECOMBINANT INTERFERON ALPHA-2C
BLUT. 1985; 51(3): 233-233.
Web of Science

 

** LINKESCH, W; GISSLINGER, H; LUDWIG, H; SINZINGER, H; FLENER, R THERAPY OF EXCESSIVE THROMBOCYTOSES IN MYELOPROLIFERATIVE DISEASES WITH RECOMBINANT INTERFERON ALPHA-2C
ACTA MED AUST. 1985; 12: 48-48.
Web of Science

 

** LINKESCH, W; GISSLINGER, H; RADASZKIEWICZ, T PHASE-III STUDY WITH AMSACRINE, CYTOSINE-ARABINOSIDE, THIOGUANINE (AAT) VS DAUNORUBICIN, CYT-ARA-C, THIOGUANINE (DAT) IN UNTREATED ACUTE NON-LYMPHOBLASTIC LEUKEMIA
BLUT. 1985; 51(3): 212-212.
Web of Science

 

** LINKESCH, W; GISSLINGER, H; SINZINGER, H; LUDWIG, H INTERFERON ALPHA-2C IN THE THERAPY OF EXCESSIVE THROMBOCYTOSES IN MYELOPROLIFERATIVE DISEASES
ACTA MED AUST. 1985; 12(3-4): 88-&.
Web of Science

 

** LUDWIG, H; LINKESCH, W; KUZMITS, R; SCHEITHAUER, W; POTZI, P; KUHBOCK, J; FLENER, R RESULTS OF INTERFERON THERAPY IN MULTIPLE-MYELOMA
BLUT. 1985; 51(3): 233-233.
Web of Science

 

** SINZINGER, H; LUDWIG, H; LINKESCH, W; GISSLINGER, H; FLENER, R INTERACTION BETWEEN INTERFERON AND THE PROSTAGLANDIN SYSTEM
ACTA MED AUST. 1985; 12: 73-73.
Web of Science

 

1984

Originalarbeit (Zeitschrift)

** Linkesch, W Physiology and physiopathology of iron metabolism
WIEN MED WOCHENSCHR. 1984; 134(3-4): 59-63.
Web of Science PubMed

 

** Linkesch, W Serum ferritin--its diagnostic relevance and clinical significance
ACTA MED AUST. 1984; 11(3-4): 79-89. (- Case Report)
Web of Science PubMed

 

Abstract (Zeitschrift)

** BETTELHEIM, P; LUTZ, D; MAJDIC, O; NEUMANN, E; HAAS, O; LINKESCH, W; PAIETTA, E; LECHNER, K; KNAPP, W HETEROGENEITY IN CML BLAST CRISIS - IMMUNOLOGICAL PHENOTYPING IN 45 PATIENTS
BLUT. 1984; 49(3): 272-272.
Web of Science

 

** KOVARIK, J; GRAF, H; IRSCHIK, H; WOLOSZCZUK, W; MEISINGER, V; LINKESCH, W; STUMMVOLL, HK; PINGGERA, WF TREATMENT OF IRON OVERLOAD BY DESFERRIOXAMINE (DFO) IN PATIENTS ON CHRONIC-HEMODIALYSIS (CHD) WITH TRANSFUSION DEPENDENT ANEMIA
KIDNEY INT. 1984; 26(4): 568-568.
Web of Science

 

** KUZMITS, R; AIGINGER, P; MULLER, MM; STEURER, G; SCHWARZ, HP; LINKESCH, W; LUDWIG, H DETERMINATION OF DRUG-INDUCED CYTO-TOXICITY IN LEUKEMIC-CELLS USING BIOLUMINESCENCE
BLUT. 1984; 49(3): 275-276.
Web of Science

 

** LINKESCH, W; KOVARIK, J; WOLOSZCZUK, W; MEISINGER, V; IRSCHIK, H LONG-TERM TREATMENT WITH DESFERRIOXAMINE (DFO) IN HEMODIALYSIS (HD)-RELATED HEMOSIDEROSIS
BLUT. 1984; 49(3): 245-245.
Web of Science

 

** PREIS, P; ZIELINSKI, CC; LINKESCH, W; BETTELHEIM, P; PAVELKA, M; HAAS, O; POLLAK, C; AIGINGER, P PHENOTYPIC SHIFTS FROM ACUTE LYMPHOCYTIC-LEUKEMIA (T-ALL) TO EOSINOPHILIC LEUKEMIA IN A 14-YEAR-OLD PATIENT
BLUT. 1984; 49(3): 270-270.
Web of Science

 

1983

Originalarbeit (Zeitschrift)

** Linkesch, W; Ludwig, H Serum ferritin and beta 2-microglobulin in patients with multiple myeloma.
Cancer Detect Prev. 1983; 6(1-2):297-301
Web of Science PubMed Google Scholar

 

** Luger, TA; Linkesch, W; Knobler, R; Kokoschka, EM Serial determination of serum ferritin levels in patients with malignant melanoma.
ONCOLOGY. 1983; 40(4): 263-267. Doi: 10.1159/000225740
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Scherak, O; Linkesch, W Serum ferritin as an indicator for iron substitution in patients with chronic polyarthritis
Z RHEUMATOL. 1983; 42(3): 130-132.
Web of Science PubMed

 

Abstract (Zeitschrift)

** BETTELHEIM, P; LUTZ, D; SCHMIDMEIER, W; PAIETTA, E; MAJDIC, O; LINKESCH, W; NEUMANN, E; HINTERBERGER, W; KRIEGER, O; LECHNER, K; KNAPP, W IMMUNOLOGICAL BLAST CELL CLASSIFICATION IN CASES OF DOUBLE LEUKEMIAS
ONKOLOGIE. 1983; 6(5): 217-217.
Web of Science

 

** LINKESCH, W; GRANINGER, W; SCHERNTHANER, G NEW ASPECTS IN THE TREATMENT OF HEMOCHROMATOSIS
BLUT. 1983; 47(3): 172-172.
Web of Science

 

1982

Originalarbeit (Zeitschrift)

** Braun, F; Lachmann, D; Linkesch, W Serum ferritin and nutrition in infants (author's transl)
PADIATR PADOL. 1982; 17(3): 617-621.
Web of Science PubMed

 

** Kübböck, J; Ludwig, H; Aiginger, P; Linkesch, W; Pötzi, P Treatment of metastasizing breast cancer with aminoglutethimide
ACTA MED AUST. 1982; 9(5-6): 221-226.
Web of Science PubMed

 

** Linkesch, W; Ludwig, H Serum ferritin and beta-2-microglobulin in multiple myeloma
Acta Med Austriaca. 1982; 9(5-6):227-231
Web of Science PubMed Google Scholar

 

** Polterauer, P; Linkesch, W Serum-alpha 1-fetoprotein and serumferritin in liver tumours (author's transl)
WIEN KLIN WOCHENSCHR. 1982; 94(4): 105-108.
Web of Science PubMed

 

Abstract (Zeitschrift)

** KHOSS, AE; LINKESCH, W IRON STATUS IN CHILDREN WITH CONGENITAL HEART-DISEASE
BLUT. 1982; 45(3): 209-209.
Web of Science

 

** LINKESCH, W; GLOGAR, D; MAYR, H; MLCZOCH, J; KAINDL, F MYOGLOBIN VALUES IN PATIENTS WITH CONGESTIVE CARDIOMYOPATHY
ACTA MED AUST. 1982; 9: 123-123.
Web of Science

 

** LINKESCH, W; HOCKER, P; STEINMANN, C IRON STATUS IN PLATELETPHERESIS AND LEUKAPHERESIS DONORS
BLUT. 1982; 45(3): 209-209.
Web of Science

 

** LINKESCH, W; LUDWIG, H PRODUCTION OF FERRITIN IN LEUKEMIC-CELLS
BLUT. 1982; 45(3): 207-207.
Web of Science

 

** WILLVONSEDER, R; HELLETZGRUBER, M; KOVARIK, J; ESCHBERGER, J; PLENK, H; SEIDL, G; LINKESCH, W; TILSCHER, H; WEISSEL, M CONTRIBUTION TO THE PATHO-PHYSIOLOGY OF CALCIUM-METABOLISM IN A CASE OF ALBERS-SCHONBERG OSTEOPETROSIS
ACTA MED AUST. 1982; 9(3): 10-10.
Web of Science

 

1981

Originalarbeit (Zeitschrift)

** HELLETZGRUBER, M; KOVARIK, J; PLENK, H; SEIDL, G; LINKESCH, W; TILSCHER, H; WEISSLER, M; WILLVONSEDER, R OSTEOPETROSIS (ALBERS-SCHONBERG)
MINERVA MED. 1981; 72(30): 1991-1999.
Web of Science

 

** Kovarik, J; Küster, W; Seidl, G; Linkesch, W; Dorda, W; Willvonseder, R; Kotscher, E Clinical relevance of radiologic examination of the skeleton and bone density measurements in osteoporosis of old age.
Skeletal Radiol. 1981; 7(1):37-41 Doi: 10.1007/BF00347170
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Linkesch, W; Aiginger, P Tumour associated proteins (author's transl)
Radiobiol Radiother (Berl). 1981; 22(1): 121-125.
PubMed

 

** Pavelka, R; Kofler, E; Linkesch, W; Pollak, A Serum ferritin in pregnancy at term and in newborn (author's transl)
PADIATR PADOL. 1981; 16(4): 443-450.
Web of Science PubMed Google Scholar

 

** Pavelka, R; Linkesch, W; Kofler, E Hematologic parameters and iron state in the perinatal period.
ARCH GYNECOL. 1981; 230(4): 275-281. Doi: 10.1007/BF02199675
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Zeitschrift)

** AIGINGER, P; KOLBE, H; KUZMITS, R; KUHBOCK, J; LINKESCH, W; SPONA, J; ARDALAN, B PROGNOSTIC VALUE OF ALPHA-1 FETOPROTEIN, BETA-HUMAN CHORIONGONADOTROPIN AND FERRITIN IN METASTASIZED TESTICULAR CANCER
PROC AMER ASS CANCER RES. 1981; 22(MAR): 347-347.
Web of Science

 

** GLOGAR, DH; MAYR, H; MLCZOCH, J; LINKESCH, W; PROBST, P; PACHINGER, O; ZASMETA, H; KAINDL, F CLINICAL PROGNOSIS IN CASES OF CONGESTIVE CARDIOMYOPATHY - PATIENT COLLECTIVE 1974-1980
ACTA MED AUST. 1981; 8: 170-170.
Web of Science

 

** LINKESCH, W; GLOGAR, D; MAYR, H; MLCZOCH, J; PACHINGER, O SERUM FERRITIN IN PATIENTS WITH CONGESTIVE CARDIOMYOPATHY
ACTA MED AUST. 1981; 8: 177-177.
Web of Science

 

** LINKESCH, W; GLOGAR, D; MLCZOCH, J; MAYR, H; PACHINGER, O SERUM FERRITIN IN CONGESTIVE CARDIOMYOPATHY
Z KARDIOL. 1981; 70(8): 628-628.
Web of Science

 

** LINKESCH, W; SINZINGER, H; SILBERBAUER, K THROMBOCYTE SURVIVAL-TIME IN MYELOPROLIFERATIVE DISEASES
ACTA MED AUST. 1981; 8: 194-195.
Web of Science

 

** MAYR, H; GLOGAR, D; LINKESCH, W; MLCZOCH, J; PROBST, P IMMUNOGLOBULIN-E IN CONGESTIVE CARDIOMYOPATHY
Z KARDIOL. 1981; 70(8): 628-628.
Web of Science

 

** SILBERBAUER, K; LINKESCH, W; SINZINGER, H THROMBOCYTE FUNCTION DISTURBANCE IN PATIENTS WITH MYELOPROLIFERATIVE SYNDROME
ACTA MED AUST. 1981; 8: 200-200.
Web of Science

 

1980

Originalarbeit (Zeitschrift)

** Helletzgruber, M; Kovarik, J; Plenk, H; Seidl, G; Linkesch, W; Tilscher, H; Weissel, M; Willvonseder, R Osteopetrosis (Albers-Schönberg) (author's transl)
DEUT MED WOCHENSCHR. 1980; 105(42): 1463-1468. Doi: 10.1055/s-2008-1070893 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

** LINKESCH, W; SCHERAK, O; KOLBE, H SERUM FERRITIN IN RHEUMATOID-ARTHRITIS PATIENTS
Z RHEUMATOL. 1980; 39: 46-49.
Web of Science

 

** LINKESCH, W; SCHERAK, O; MULLER, MM HEMOSYNTHESIS IN RHEUMATOID-ARTHRITIS PATIENTS
Z RHEUMATOL. 1980; 39: 33-35.
Web of Science

 

Kurzbericht/Letter

** Kovarik, J; Woloszczuk, W; Linkesch, W; Pavelka, R Calcitonin in pregnancy.
LANCET. 1980; 1(8161): 199-200.
Web of Science PubMed Google Scholar

 

Abstract (Zeitschrift)

** AIGINGER, P; KUZMITS, R; LINKESCH, W; KUHBOCK, J FUCOSYL-TRANSFERASE AND FERRITIN IN DIAGNOSIS OF RECURRENT MALIGNANT TESTICULAR-TUMORS
BLUT. 1980; 41(4): 305-305.
Web of Science

 

** KOVARIK, J; WOLOSZCZUK, W; GRAF, H; LINKESCH, W; PAVELKA, R CALCIUM REGULATING HORMONES DURING PREGNANCY AND IN NEWBORN BABIES
J CLIN CHEM CLIN BIOCHEM. 1980; 18(10): 747-747.
Web of Science

 

** LINKESCH, W; SCHWARZ, P; KUHBOCK, J HEME-SYNTHESIS AND IRON STATUS IN PATIENTS WITH POLYCYTHEMIA-VERA
BLUT. 1980; 41(4): 286-287.
Web of Science

 

1979

Originalarbeit (Zeitschrift)

** Linkesch, W; Luger, T; Kokoschka, EM Serum ferritin in patients with malignant melanoma
Acta Med Austriaca Suppl. 1979; 6(42): 346-349.
PubMed

 

** Linkesch, W; Müller, M; Scherak, O New aspects in the pathogenesis of anemia in chronic polyarthritis
Acta Med Austriaca Suppl. 1979; 6(42): 387-389.
PubMed

 

** Linkesch, W; Pavelka, R; Kofler, E; Müller, M Heme synthesis and iron status in pregnancy
Acta Med Austriaca Suppl. 1979; 6(42): 368-372.
PubMed

 

Abstract (Zeitschrift)

** LEGENSTEIN, E; LINKESCH, W; MULLER, MM DETERMINATION OF FERROCHETALASE IN WHOLE-BLOOD
J CLIN CHEM CLIN BIOCHEM. 1979; 17(3): 177-177.
Web of Science

 

** LINKESCH, W CLINICAL SIGNIFICANCE OF SERUM FERRITIN
WIEN KLIN WOCHENSCHR. 1979; 91(10): 360-361.
Web of Science

 

** LINKESCH, W; LEGENSTEIN, E; MULLER, MM DETERMINATION OF HEME-SYNTHESIZING ENZYMES IN WHOLE-BLOOD IN DIFFERENT TYPES OF ANEMIA
J CLIN CHEM CLIN BIOCHEM. 1979; 17(3): 178-178.
Web of Science

 

1978

Originalarbeit (Zeitschrift)

** Linkesch, W Serum ferritin- diagnostic and clinical significance
Acta Med Austriaca. 1978; 5(4-5): 169-171.
PubMed

 

** Linkesch, W; Bergmann, H; Steinbach, K; Weissel, M Renal hemosiderosis and sideropenic hemolytic anemia after heart valve replacement
Verh Dtsch Ges Inn Med. 1978; 5(84): 107-111.
PubMed

 

** Linkesch, W; Glogar, D; Niederberger, M Clinical efficacy of perhexiline maleate in stable angina pectoris (author's transl)
WIEN KLIN WOCHENSCHR. 1978; 90(16): 598-603.
Web of Science PubMed

 

** Linkesch, W; Stummvoll, HK; Wolf, A; Müller, M Heme synthesis in anemia of the uremic state.
Isr J Med Sci. 1978; 14(11):1173-1176
Web of Science PubMed Google Scholar

 

Abstract (Zeitschrift)

** LINKESCH, W; PAVELKA, R; KOFLER, E; HOFER, R SERUM FERRITIN IN NORMAL AND PATHOLOGICAL PREGNANCIES
BLUT. 1978; 37(3): 154-155.
Web of Science

 

1977

Kurzbericht/Letter

** Weissel, M; Wolf, A; Linkesch, W Acute suppurative thyroiditis caused by pseudomonas aeruginosa.
Br Med J. 1977; 2(6086):580-580 Doi: 10.1136/bmj.2.6086.580-b (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Zeitschrift)

** LINKESCH, W; KORNAUTH, W; KUHBOCK, J; POTZI, P STIMULABILITY OF GRANULOPOIESIS AND CYTOSTATIC TOLERANCE
BLUT. 1977; 35(4): 353-353.
Web of Science

 

Kurzbericht/Note

** Linkesch, W; Bergmann, H; Endler, F; Kolarz, G; Höfer, R Investigations of the final settling of implanted hip-joints by use of 85Sr (author's transl)
Z ORTHOP GRENZGEB. 1977; 115(1): 108-112.
Web of Science PubMed

 

1975

Abstract (Zeitschrift)

** KUHBOCK, J; LINKESCH, W; POTZI, P EFFECT OF SPLENECTOMY ON CYTOSTATIC TOLERANCE IN HODGKINS-DISEASE
BLUT. 1975; 31(3): 175-175.
Web of Science

 

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum